- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID AHH-1
AC CVCL_3640
SY AHH1
DR CLO; CLO_0001688
DR ATCC; CRL-8146
DR BioSample; SAMN03471195
RX Patent=US4532204;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,13
ST D16S539: 10
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2710 ! RPMI-1788
SX Male
CA Transformed cell line
//
ID AHL-1
AC CVCL_4611
SY AHL 1; AHL1; Armenian Hamster Lung-1
DR CLO; CLO_0001689
DR CLDB; cl261
DR ECACC; 90120504
DR ATCC; CCL-195
DR Wikidata; Q18205164
RX CelloPub=CLPUB00292;
RX PubMed=7065527;
WW https://en.wikipedia.org/wiki/AHL-1_cells
CC Discontinued: ECACC; 90120504; probable.
OX NCBI_TaxID=10032; ! Cricetulus migratorius
SX Male
CA Spontaneously immortalized cell line
//
ID AI0009
AC CVCL_8B79
DR ECACC; 90102303
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AI0249
AC CVCL_8B80
DR ECACC; 95031607
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AICHI-4
AC CVCL_5G39
RX PubMed=5728341;
CC Doubling time: ~24 hours (PubMed=5728341).
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AIG
AC CVCL_8483
DR JCRB; JCRB1105
DR JCRB; NIHS0387
RX PubMed=1170023;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Discontinued: JCRB; NIHS0387; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Transformed cell line
//
ID AIK-T4
AC CVCL_1B42
DR ChEMBL-Cells; CHEMBL3307276
DR ChEMBL-Targets; CHEMBL614024
RX PubMed=8608235;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1B43 ! AIK-T8
SX Female
CA Transformed cell line
//
ID AIK-T8
AC CVCL_1B43
DR ChEMBL-Cells; CHEMBL3308406
DR ChEMBL-Targets; CHEMBL613504
RX PubMed=8608235;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1B42 ! AIK-T4
SX Female
CA Transformed cell line
//
ID AILNCaP
AC CVCL_U984
SY AI LNCaP; AI-LNCaP; Androgen-Independent LNCaP
DR BTO; BTO:0004799
RX PubMed=16931574;
CC Derived from metastatic site: Left supraclavicular lymph node.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0395 ! LNCaP
SX Male
CA Cancer cell line
//
ID Ainv15
AC CVCL_6563
SY AinV15; Ain V15
DR CLO; CLO_0001690
DR ATCC; SCRC-1029
RX PubMed=11955444;
CC Transfected with: UniProtKB; P42212; GFP.
CC Discontinued: ATCC; SCRC-1029; true.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_X727 ! E14-nlsrtTA-7
SX Male
CA Embryonic stem cell
//
ID Ainv18
AC CVCL_2G81
SY AinV18; Ain V18; Ainv-18; Ainv 18
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_X727 ! E14-nlsrtTA-7
SX Male
CA Embryonic stem cell
//
ID aIR-1
AC CVCL_K040
SY anti-IR-1; alpha IR-1
DR CLO; CLO_0009734
DR ATCC; HB-175
RX PubMed=6304046;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID aIR-2
AC CVCL_K041
SY anti-IR-2; alpha IR-2
RX PubMed=6304046;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID aIR-3
AC CVCL_K042
SY anti-IR-3; alpha IR-3
RX PubMed=6304046;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID AJ8
AC CVCL_N321
DR ATCC; HB-8339
RX Patent=US4935344;
CC Discontinued: ATCC; HB-8339; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID AK-D
AC CVCL_3641
SY AKD
DR CLO; CLO_0001692
DR CLDB; cl263
DR CLDB; cl5135
DR ATCC; CCL-150
DR ECACC; 89071903
RX PubMed=1271751;
RX PubMed=7065527;
OX NCBI_TaxID=9685; ! Felis catus
CA Spontaneously immortalized cell line
//
ID AK778
AC CVCL_W745
SY AK 778
RX PubMed=1325212;
RX PubMed=3080238;
RX PubMed=6286763;
RX PubMed=7757991;
RX PubMed=8515068;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Akata
AC CVCL_0148
SY AKATA; Akata-BL; Akata BL
DR MCCL; MCC:0000041
DR Cosmic; 931094
DR Cosmic; 2301567
DR NCBI_Iran; C451
DR TOKU-E; 3580
RX PubMed=1647567;
RX PubMed=1915267;
RX PubMed=9473234;
RX PubMed=9973220;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Akata 2A8
AC CVCL_6247
SY 2A8
DR Lonza; 137
RX PubMed=9593003;
RX PubMed=10022853;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Characteristics: EBV-negative. Treated with hydroxyurea which completely eliminated EBV episomes.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0148 ! Akata
SX Female
CA Cancer cell line
//
ID Akata 2C1
AC CVCL_6248
SY 2C1
RX PubMed=9593003;
RX PubMed=10022853;
CC Characteristics: EBV-negative. Treated with hydroxyurea which completely eliminated EBV episomes.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0148 ! Akata
SX Female
CA Cancer cell line
//
ID Akata 3F2
AC CVCL_6249
SY 3F2
RX PubMed=9593003;
RX PubMed=10022853;
CC Characteristics: EBV-negative. Treated with hydroxyurea which completely eliminated EBV episomes.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0148 ! Akata
SX Female
CA Cancer cell line
//
ID Akata EG
AC CVCL_6250
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0148 ! Akata
SX Female
CA Cancer cell line
//
ID AKH12
AC CVCL_0C56
DR TOKU-E; 3989
RX PubMed=16809312;
CC From: Eisenbauer A.; Institute of Cancer Research of the Medical University of Vienna; Vienna; Austria.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AKH13
AC CVCL_0C57
DR Cosmic; 2162535
DR TOKU-E; 3990
RX PubMed=16809312;
RX PubMed=23887712;
CC From: Eisenbauer A.; Institute of Cancer Research of the Medical University of Vienna; Vienna; Austria.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AKI
AC CVCL_8170
DR BioSample; SAMN03151663
DR RCB; RCB0408
RX PubMed=3145150;
RX PubMed=16643607;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=16643607, PubMed=20143388). Originally thought to originate from a melanoma in a male patient.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: RCB; RCB0408; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID AKIBA
AC CVCL_E453
DR dbMHC; 48471
DR ECACC; 94022520
DR IHW; IHW9286
DR IMGT/HLA; 10239
RX PubMed=16702430;
WW http://bioinformatics.hsanmartino.it/ecbr/cl286.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AKR-2B
AC CVCL_4103
SY AKR mouse embryo cells clone 2B
DR CLO; CLO_0001701
DR CLDB; cl264
DR ECACC; 91061307
DR TOKU-E; 4150
RX PubMed=196768;
RX PubMed=679187;
RX PubMed=2706619;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=AKR-2B
CC Breed/subspecies: AKR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID AKR-MCA
AC CVCL_Y466
RX PubMed=196768;
RX PubMed=679187;
RX PubMed=2706619;
RX PubMed=6265069;
CC Breed/subspecies: AKR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4103 ! AKR-2B
CA Transformed cell line
//
ID AKR/11D
AC CVCL_3341
SY AKR/11-D; 11D12
DR CLO; CLO_0001693
DR CLDB; cl4924
DR ICLC; ATL98007
RX PubMed=1401954;
RX PubMed=7517914;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: AKR/J.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6565 ! AKR1.G.1.OUAR.1.26
CA Cancer cell line
//
ID AKR/12B-1
AC CVCL_3342
DR CLO; CLO_0001694
DR CLDB; cl4939
DR ICLC; ATL98005
RX PubMed=1401954;
RX PubMed=7517914;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: AKR/J.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6565 ! AKR1.G.1.OUAR.1.26
CA Cancer cell line
//
ID AKR/12B-2
AC CVCL_3343
DR CLO; CLO_0001695
DR CLDB; cl4925
DR ICLC; ATL98008
RX PubMed=1401954;
RX PubMed=7517914;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: AKR/J.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6565 ! AKR1.G.1.OUAR.1.26
CA Cancer cell line
//
ID AKR/12B-3
AC CVCL_3344
DR CLO; CLO_0001696
DR CLDB; cl4926
DR ICLC; ATL98009
RX PubMed=1401954;
RX PubMed=7517914;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: AKR/J.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6565 ! AKR1.G.1.OUAR.1.26
CA Cancer cell line
//
ID AKR/13B
AC CVCL_3345
DR CLO; CLO_0001697
DR CLDB; cl4927
DR ICLC; ATL98006
RX PubMed=1401954;
RX PubMed=7517914;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: AKR/J.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6565 ! AKR1.G.1.OUAR.1.26
CA Cancer cell line
//
ID AKR/14C
AC CVCL_3346
SY 14C6
DR CLO; CLO_0001698
DR CLDB; cl4928
DR ICLC; ATL98010
RX PubMed=1401954;
RX PubMed=7517914;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: AKR/J.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6565 ! AKR1.G.1.OUAR.1.26
CA Cancer cell line
//
ID AKR/JA.Sp
AC CVCL_6564
DR CLO; CLO_0001699
DR ATCC; CRL-6320
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6320; true.
CC Breed/subspecies: AKR/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Finite cell line
//
ID AKR/JB.Sp
AC CVCL_S401
DR ATCC; CRL-6321
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6321; true.
CC Breed/subspecies: AKR/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Finite cell line
//
ID AKR1.G.1.OUAR.1.26
AC CVCL_6565
SY AKR1.G.1.OVAR.1.26; AKR1(Thy-1-a) TGr; AKR1; AKR/1
DR CLO; CLO_0001700
DR ATCC; TIB-232
RX DOI=10.1007/BF01561574;
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: AKR/J.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Akuba
AC CVCL_W933
SY AKUBA
DR Cosmic; 931113
RX PubMed=170370;
RX PubMed=4122458;
RX PubMed=4364259;
RX PubMed=7316467;
RX PubMed=9473234;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AL 1-27
AC CVCL_J741
SY A 127; A127; M-11
DR CLO; CLO_0001702
DR ATCC; HB-8441
RX Patent=US4806628;
RX Patent=US4808704;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Al Ke
AC CVCL_3642
DR CLO; CLO_0001703
DR ATCC; CRL-1325
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Al Pos
AC CVCL_4J63
DR ATCC; CRL-1120
CC Discontinued: ATCC; CRL-1120; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID AL-3-11A
AC CVCL_DE34
RX PubMed=20020445;
CC Transformant: Ad5-SV40.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AL-4-17
AC CVCL_DE35
RX PubMed=20020445;
CC Transformant: Ad5-SV40.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AL/N
AC CVCL_6312
SY N AL/N
DR CLO; CLO_0001704
DR ATCC; CRL-6506
RX PubMed=4302577;
RX PubMed=4331720;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6506; true.
CC Breed/subspecies: AL/N.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID AL1
AC CVCL_X931
SY AL-1
DR CGH-DB; 9189-4
RX PubMed=4321974;
RX PubMed=5902320;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ALA
AC CVCL_J358
SY Ala; HCT-ALA
DR Cosmic; 711270
DR Cosmic; 887234
DR Cosmic; 1479575
RX PubMed=3349466;
RX PubMed=7329817;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=11526487;
CC Microsatellite instability: Stable (MSS) (PubMed=9000147).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AlAb
AC CVCL_U957
SY ALAB; Alab; A1Ab
DR ATCC; CRL-7715
DR Cosmic; 1218871
DR GEO; GSM783944
RX PubMed=212193;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=14490970;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7715; true.
CC Derived from metastatic site: Lung.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ALBA
AC CVCL_F698
DR IMGT/HLA; 12067
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ALC [Mouse ameloblast]
AC CVCL_1947
SY Ameloblast-Lineage Cells
RX PubMed=12927794;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID ALC [Mouse bone marrow]
AC CVCL_0E84
RX PubMed=2435412;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID ALF
AC CVCL_M035
RX PubMed=15767549;
CC Part of: JFCR45 cancer cell line panel.
CC Miscellaneous: Only mentioned as a stomach cancer cell line in PubMed=15767549.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ali-BL
AC CVCL_7172
SY Ali
RX PubMed=9882297;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ALKO
AC CVCL_5I28
SY Astrocyte LKB1 knock out
WW https://www.kerafast.com/product/2226/astrocyte-lkb1-knock-out-cell-line-alko
CC Doubling time: 18-24 hours (Kerafast).
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1341870; Stk11.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID ALL-7031-B
AC CVCL_0B39
SY 7031-B
RX PubMed=3495441;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ALL-PO
AC CVCL_1069
DR CLO; CLO_0001705
DR CLDB; cl5399
DR ChEMBL-Cells; CHEMBL3308227
DR ChEMBL-Targets; CHEMBL2366294
DR Cosmic; 910944
DR Cosmic-CLP; 910944
DR GDSC; 910944
DR GEO; GSM1669596
DR ICLC; HTL01003
RX PubMed=9444945;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; ICLC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 13
ST D21S11: 29,30
ST D5S818: 11,12
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23) MLL rearranged
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ALL-SIL
AC CVCL_1805
SY ALLSIL; SIL-ALL
DR BTO; BTO:0005360
DR BioSample; SAMN03473514
DR CCLE; ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 721715
DR Cosmic; 913404
DR Cosmic; 933537
DR Cosmic; 996306
DR Cosmic; 998724
DR Cosmic; 1037687
DR Cosmic; 1115585
DR Cosmic; 1175126
DR Cosmic; 1224372
DR Cosmic; 1330498
DR Cosmic; 1524789
DR Cosmic; 1641391
DR Cosmic; 1664519
DR Cosmic; 1760517
DR Cosmic; 2165718
DR Cosmic-CLP; 1295740
DR DSMZ; ACC-511
DR GDSC; 1295740
DR GEO; GSM1669597
RX PubMed=10071127;
RX PubMed=17117183;
RX PubMed=22675565;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~48 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Misspelling: 'AL:L-SIL' in Cosmic 913404.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 10,12
ST D5S818: 11,13
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 10,11
ST vWA: 17
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ALL/MIK
AC CVCL_W883
RX PubMed=8167560;
DI NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AllSi-Heart
AC CVCL_DA19
RX DOI=10.1007/s11434-011-4622-9;
CC Group: Reptilian cell line.
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the species and the name of the tissue.
OX NCBI_TaxID=38654; ! Alligator sinensis
OI CVCL_DA20 ! AllSi-Liver
OI CVCL_DA21 ! AllSi-Muscle
SX Sex undetermined
CA Finite cell line
//
ID AllSi-Liver
AC CVCL_DA20
RX DOI=10.1007/s11434-011-4622-9;
CC Group: Reptilian cell line.
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the species and the name of the tissue.
OX NCBI_TaxID=38654; ! Alligator sinensis
OI CVCL_DA19 ! AllSi-Heart
OI CVCL_DA21 ! AllSi-Muscle
SX Sex undetermined
CA Finite cell line
//
ID AllSi-Muscle
AC CVCL_DA21
RX DOI=10.1007/s11434-011-4622-9;
CC Group: Reptilian cell line.
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the species and the name of the tissue.
OX NCBI_TaxID=38654; ! Alligator sinensis
OI CVCL_DA19 ! AllSi-Heart
OI CVCL_DA20 ! AllSi-Liver
SX Sex undetermined
CA Finite cell line
//
ID ALMC-1
AC CVCL_M525
RX CelloPub=CLPUB00252;
RX PubMed=18567838;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M526 ! ALMC-2
SX Female
CA Cancer cell line
//
ID ALMC-2
AC CVCL_M526
RX CelloPub=CLPUB00252;
RX PubMed=18567838;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M525 ! ALMC-1
SX Female
CA Cancer cell line
//
ID alpha-ACE 3.1.1
AC CVCL_K122
SY ACE 3.1.1; a-ACE 3.1.1
DR CLO; CLO_0009730
DR ATCC; HB-8191
RX Patent=US4582790;
RX PubMed=6296854;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID alpha T1
AC CVCL_AW09
RX PubMed=2562221;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID alpha T2
AC CVCL_AW10
SY alphaT2
RX PubMed=1694016;
RX PubMed=2562221;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Alpha-TSH
AC CVCL_U364
SY alpha TSH
RX PubMed=1704102;
RX PubMed=15541569;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID alphaPIG-AT25-miPSC
AC CVCL_IS70
RX PubMed=27879210;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transfected with: UniProtKB; P13249; S.alboniger pac.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: C57BL/6 x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_IS69 ! TiB7-4
CA Induced pluripotent stem cell
//
ID AlphaT1-1
AC CVCL_U463
SY Alpha-T1-1
RX PubMed=8898243;
RX PubMed=15541569;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_U355 ! TalphaT1
CA Transformed cell line
//
ID AlphaT3-1
AC CVCL_0149
SY AlphaT31; alphaT3-1; alpha T3-1; alpha-T3-1
DR BTO; BTO:0003566
DR MCCL; MCC:0000042
RX PubMed=1704103;
RX PubMed=8898243;
RX PubMed=15541569;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID alphaTC1
AC CVCL_B035
SY alpha-TC1; alpha TC1; aTC1
RX PubMed=2156740;
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID alphaTC1 Clone 6
AC CVCL_B036
SY alpha TC1 clone 6; alphaTC clone 6; alpha-TC1.6; alpha-TC1-6; alpha TC1-6; alpha TC1.6; aTC1 Clone 6; aTC1-6
DR BTO; BTO:0002982
DR ATCC; CRL-2934
DR TOKU-E; 4124
RX PubMed=2108069;
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B035 ! alphaTC1
CA Cancer cell line
//
ID alphaTC1 Clone 9
AC CVCL_0150
SY alpha TC1 clone 9; alphaTC clone 9; alpha-TC1.9; alpha-TC1-9; aTC1 Clone 9; aTC1-9
DR BTO; BTO:0002981
DR CLO; CLO_0009736
DR MCCL; MCC:0000495
DR ATCC; CRL-2350
RX PubMed=2108069;
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B035 ! alphaTC1
CA Cancer cell line
//
ID alphaTN4
AC CVCL_AW08
RX PubMed=1694016;
RX PubMed=2178867;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_AW10 ! alpha T2
CA Transformed cell line
//
ID alphaTN4-1
AC CVCL_D858
SY alpha TN4-1
DR BTO; BTO:0001872
RX PubMed=1694016;
RX PubMed=9990330;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_AW08 ! alphaTN4
CA Transformed cell line
//
ID alphaTN6
AC CVCL_AW11
RX PubMed=1694016;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_AW10 ! alpha T2
CA Transformed cell line
//
ID ALS-iPS1
AC CVCL_L641
DR ISCR; 1961
RX PubMed=22673189;
CC From: Guangzhou Medical College; China.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L642 ! ALS-iPS2
SX Male
CA Induced pluripotent stem cell
//
ID ALS-iPS2
AC CVCL_L642
DR ISCR; 1962
RX PubMed=22673189;
CC From: Guangzhou Medical College; China.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L641 ! ALS-iPS1
SX Male
CA Induced pluripotent stem cell
//
ID ALST
AC CVCL_W778
RX PubMed=10972993;
RX PubMed=11793438;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ALT
AC CVCL_Y087
DR BCRC; 60581
RX PubMed=21894147;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID ALT-F
AC CVCL_B328
SY ALTF
DR Cosmic; 889538
RX PubMed=7960578;
RX PubMed=11964082;
CC Derived from metastatic site: Liver.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B329 ! ALT-G
OI CVCL_B330 ! ALT-I
CA Cancer cell line
//
ID ALT-G
AC CVCL_B329
SY ALTG
DR Cosmic; 889539
RX PubMed=7960578;
RX PubMed=11964082;
CC Derived from metastatic site: Lymph node.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B328 ! ALT-F
OI CVCL_B330 ! ALT-I
CA Cancer cell line
//
ID ALT-I
AC CVCL_B330
SY ALTI
DR Cosmic; 889537
DR Cosmic; 902792
RX PubMed=7960578;
RX PubMed=11964082;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B328 ! ALT-F
OI CVCL_B329 ! ALT-G
CA Cancer cell line
//
ID ALTS1C1
AC CVCL_Y088
DR BCRC; 60582
RX PubMed=21894147;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Y087 ! ALT
SX Male
CA Transformed cell line
//
ID ALTS1C1-SDFkd
AC CVCL_GT22
SY ALTS1C1 (SDFkd)
DR BCRC; 60608
RX PubMed=21894147;
CC Knockout cell: Method=siRNA knockdown; MGI; MGI:103556; Cxcl12.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Y088 ! ALTS1C1
SX Male
CA Transformed cell line
//
ID ALVA-101
AC CVCL_4735
SY ALVA 101; ALVA101; American Lake VA-101
DR BioSample; SAMN03151888
RX PubMed=1958578;
RX PubMed=8561862;
RX PubMed=9018337;
RX PubMed=12725112;
RX PubMed=14518029;
RX PubMed=20143388;
WW http://capcelllines.ca/details.asp?id=170
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=14518029, PubMed=20143388).
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID ALVA-31
AC CVCL_4737
SY ALVA 31; ALVA31; American Lake VA-31
DR BTO; BTO:0003850
DR BioSample; SAMN03151889
RX PubMed=7681207;
RX PubMed=8561862;
RX PubMed=12725112;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID ALVA-38
AC CVCL_Y656
SY ALVA38; American Lake VA-38
RX PubMed=8561862;
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ALVA-41
AC CVCL_4734
SY ALVA 41; ALVA41; American Lake VA-41
DR BTO; BTO:0002006
DR BioSample; SAMN03151890
RX PubMed=1958578;
RX PubMed=7533340;
RX PubMed=8561862;
RX PubMed=12725112;
RX PubMed=20143388;
WW http://capcelllines.ca/details.asp?id=84
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID ALVA-55
AC CVCL_4736
SY ALVA55; American Lake VA-55
DR BioSample; SAMN03151891
RX PubMed=8561862;
RX PubMed=14518029;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=14518029, PubMed=20143388).
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID ALZ.1
AC CVCL_W671
DR IZSLER; BS ALZ 1
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.10
AC CVCL_W679
DR IZSLER; BS ALZ 10
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.11
AC CVCL_W680
DR IZSLER; BS ALZ 11
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.12
AC CVCL_W681
DR IZSLER; BS ALZ 12
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.13
AC CVCL_W682
DR IZSLER; BS ALZ 13
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.14
AC CVCL_W683
DR IZSLER; BS ALZ 14
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.15
AC CVCL_W684
DR IZSLER; BS ALZ 15
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.16
AC CVCL_W685
DR IZSLER; BS ALZ 16
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.17
AC CVCL_W686
DR IZSLER; BS ALZ 17
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.18
AC CVCL_W687
DR IZSLER; BS ALZ 18
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.19
AC CVCL_W688
DR IZSLER; BS ALZ 19
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.2
AC CVCL_W672
DR IZSLER; BS ALZ 2
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.20
AC CVCL_W689
DR IZSLER; BS ALZ 20
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.21
AC CVCL_W690
DR IZSLER; BS ALZ 21
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.22
AC CVCL_W691
DR IZSLER; BS ALZ 22
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.23
AC CVCL_W692
DR IZSLER; BS ALZ 23
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.24
AC CVCL_W693
DR IZSLER; BS ALZ 24
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.25
AC CVCL_W694
DR IZSLER; BS ALZ 25
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.26
AC CVCL_W695
DR IZSLER; BS ALZ 26
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.27
AC CVCL_W696
DR IZSLER; BS ALZ 27
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.28
AC CVCL_W697
DR IZSLER; BS ALZ 28
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.29
AC CVCL_W698
DR IZSLER; BS ALZ 29
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.3
AC CVCL_W673
DR IZSLER; BS ALZ 3
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.30
AC CVCL_W699
DR IZSLER; BS ALZ 30
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.31
AC CVCL_W700
DR IZSLER; BS ALZ 31
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.32
AC CVCL_W701
DR IZSLER; BS ALZ 32
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.33
AC CVCL_W702
DR IZSLER; BS ALZ 33
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.34
AC CVCL_W703
DR IZSLER; BS ALZ 34
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.35
AC CVCL_W704
DR IZSLER; BS ALZ 35
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.38
AC CVCL_W705
DR IZSLER; BS ALZ 38
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.39
AC CVCL_W706
DR IZSLER; BS ALZ 39
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.4
AC CVCL_W674
DR IZSLER; BS ALZ 4
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.40
AC CVCL_W707
DR IZSLER; BS ALZ 40
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.41
AC CVCL_W708
DR IZSLER; BS ALZ 41
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.42
AC CVCL_W709
DR IZSLER; BS ALZ 42
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.43
AC CVCL_W710
DR IZSLER; BS ALZ 43
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.44
AC CVCL_W711
DR IZSLER; BS ALZ 44
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.5
AC CVCL_W675
DR IZSLER; BS ALZ 5
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.6
AC CVCL_W676
DR IZSLER; BS ALZ 6
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.7
AC CVCL_W677
DR IZSLER; BS ALZ 7
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID ALZ.9
AC CVCL_W678
DR IZSLER; BS ALZ 9
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID AM
AC CVCL_E454
SY AMR
DR dbMHC; 48472
DR ECACC; 94022521
DR IHW; IHW9206
DR IMGT/HLA; 10244
WW http://bioinformatics.hsanmartino.it/ecbr/cl206.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94022521; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Am Coo
AC CVCL_3306
DR CLO; CLO_0001707
DR ATCC; CRL-1286
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Am II
AC CVCL_HF26
SY AM II; AmII
RX PubMed=516912;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID Am Ric
AC CVCL_3307
DR CLO; CLO_0001708
DR ATCC; CRL-1129
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Am Tim
AC CVCL_U765
DR ATCC; CRL-1270
CC Discontinued: ATCC; CRL-1270; true.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AM-1
AC CVCL_4Z40
DR Cosmic; 2163016
DR Cosmic; 2209114
RX PubMed=9682983;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI NCIt; C4313; Ameloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AM-38
AC CVCL_1070
SY AM38; AM
DR BioSample; SAMN03470932
DR CCLE; AM38_CENTRAL_NERVOUS_SYSTEM
DR CGH-DB; 139-1
DR ChEMBL-Cells; CHEMBL3308829
DR ChEMBL-Targets; CHEMBL2366192
DR Cosmic; 685873
DR Cosmic; 910933
DR Cosmic; 1746962
DR Cosmic; 2302334
DR Cosmic; 2367507
DR Cosmic; 2516013
DR Cosmic-CLP; 910933
DR GDSC; 910933
DR GEO; GSM326247
DR GEO; GSM886866
DR GEO; GSM887931
DR GEO; GSM1669598
DR IFO; IFO50492
RX PubMed=7947440;
RX PubMed=8145054;
RX PubMed=16232199;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 72 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,13
ST D18S51: 13
ST D19S433: 14
ST D21S11: 30
ST D2S1338: 19,24
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 12
ST D8S1179: 13,14
ST FGA: 23,25
ST Penta D: 13
ST Penta E: 5,18
ST TH01: 7
ST TPOX: 11
ST vWA: 17,18 (Cosmic-CLP)
ST vWA: 17 (JCRB; PubMed=25877200)
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AM-C6SC8
AC CVCL_1948
SY AMC6SC8; AMc6sc8
DR CLO; CLO_0001712
DR CLDB; cl266
DR DSMZ; ACC-152
RX DOI=10.1007/BF03191992;
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_HF26 ! Am II
CA Spontaneously immortalized cell line
//
ID AM-HLH
AC CVCL_IP72
RX PubMed=27813134;
CC Characteristics: Contains multiple intergrated copies of the EBV genome.
CC Doubling time: 35-40 hours (PubMed=27813134).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AM-iPS-1
AC CVCL_D904
SY Mint; AM-iPS-01
DR SKIP; SKIP000365
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-10
AC CVCL_D905
SY Angelica
DR SKIP; SKIP000370
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-11
AC CVCL_D906
SY Oregano
DR SKIP; SKIP000371
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-12
AC CVCL_D907
SY Fennel
DR SKIP; SKIP000372
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-13
AC CVCL_D908
SY Basil
DR SKIP; SKIP000363
RX PubMed=21155951;
RX PubMed=21637780;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-15
AC CVCL_D909
SY Anise
DR SKIP; SKIP000373
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-16
AC CVCL_D910
SY Parsley
DR SKIP; SKIP000374
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-17
AC CVCL_D911
SY Myrtle
DR SKIP; SKIP000375
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-18
AC CVCL_D912
SY Savory
DR SKIP; SKIP000376
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-19
AC CVCL_D913
SY Chamomile
DR SKIP; SKIP000377
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-2
AC CVCL_D914
SY Clary; AM-iPS-02
DR SKIP; SKIP000366
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-20
AC CVCL_D915
SY Lovage
DR SKIP; SKIP000364
RX PubMed=21155951;
RX PubMed=21637780;
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-3
AC CVCL_D916
SY Sage; AM-iPS-03
DR SKIP; SKIP000359
RX PubMed=21155951;
RX PubMed=21637780;
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-4
AC CVCL_D917
SY Laurier; AM-iPS-04
DR SKIP; SKIP000367
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-5
AC CVCL_D918
SY Chives; AM-iPS-05
DR SKIP; SKIP000360
RX PubMed=21155951;
RX PubMed=21637780;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-6
AC CVCL_D919
SY Hyssop; AM-iPS-06
DR SKIP; SKIP000361
RX PubMed=21637780;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-7
AC CVCL_D920
SY Marry; AM-iPS-07
DR SKIP; SKIP000368
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-8
AC CVCL_D921
SY Thyme; AM-iPS-08
DR SKIP; SKIP000362
RX PubMed=21155951;
RX PubMed=21637780;
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM-iPS-9
AC CVCL_D922
SY Sorrel; AM-iPS-09
DR SKIP; SKIP000369
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D691 ! AM936EP
SX Female
CA Induced pluripotent stem cell
//
ID AM0249
AC CVCL_8B81
DR ECACC; 92060801
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34368; Alpha thalassemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Am1010
AC CVCL_W188
RX PubMed=20418894;
CC Derived from metastatic site: Upper arm muscle.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID aM346C7C1
AC CVCL_K043
SY alphaM346C7C1; anti M346C7C1
DR CLO; CLO_0009735
DR ATCC; HB-11124
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AM936EP
AC CVCL_D691
RX PubMed=21155951;
RX PubMed=21637780;
RX PubMed=23631808;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AMAI
AC CVCL_E455
SY AMAL
DR dbMHC; 48473
DR ECACC; 94070701
DR IHW; IHW9010
DR IMGT/HLA; 10246
WW http://bioinformatics.hsanmartino.it/ecbr/cl10.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AMALA
AC CVCL_E456
SY AZL
DR CLDB; cl7225
DR dbMHC; 48474
DR ECACC; 88052064
DR ICLC; HTL14002
DR IHW; IHW9064
DR IMGT/HLA; 10247
DR PRIDE; PXD001205
RX PubMed=7652742;
RX PubMed=8307784;
RX PubMed=25502872;
WW http://bioinformatics.hsanmartino.it/ecbr/cl64.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: HLA class II peptidome analysis by proteomics.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AMC-106
AC CVCL_9477
SY AMC106
DR Cosmic; 1109110
DR Cosmic; 1543773
DR GEO; GSM692873
RX PubMed=7838528;
RX PubMed=22213050;
CC Omics: Transcriptome analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AMC-60-TC
AC CVCL_F917
SY AMC-60
DR TKG; TKG 0114
DR TKG; TKG 0647
CC Breed/subspecies: ACI/N.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID AMC-hES1
AC CVCL_B524
DR ISCR; 1081
RX PubMed=18033671;
CC From: Asan Medical Center; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID AMC-hES2
AC CVCL_B525
DR ISCR; 1082
RX PubMed=18033671;
CC From: Asan Medical Center; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID AMC-HN-1
AC CVCL_5959
SY Amc-HN-1
RX PubMed=9349880;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AMC-HN-2
AC CVCL_5960
SY Amc-HN-2
RX PubMed=9349880;
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AMC-HN-3
AC CVCL_5961
SY Amc-HN-3
RX PubMed=9349880;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AMC-HN-4
AC CVCL_5962
SY Amc-HN-4
RX PubMed=9349880;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AMC-HN-5
AC CVCL_5963
SY Amc-HN-5
RX PubMed=9349880;
DI NCIt; C8192; Nasal cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AMC-HN-6
AC CVCL_5964
SY Amc-HN-6
RX PubMed=9349880;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AMC-HN-7
AC CVCL_5965
SY Amc-HN-7
RX PubMed=9349880;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AMC-HN-8
AC CVCL_5966
SY Amc-HN-8
RX PubMed=9349880;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AMC-HN-9
AC CVCL_5967
SY Amc-HN-9
RX PubMed=9349880;
RX PubMed=11039880;
DI NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Amdur II
AC CVCL_3643
AS CVCL_AW71
SY AmdurII; AMDURII; GM00050; GM-50
DR CLO; CLO_0001713
DR CLO; CLO_0025172
DR CLDB; cl270
DR CLDB; cl271
DR ATCC; CCL-124
DR BioSample; SAMN03151822
DR BioSample; SAMN03472704
DR Coriell; GM00050
DR ECACC; 90112605
DR IZSLER; BS CL 2
DR KCLB; 10124
RX CelloPub=CLPUB00290;
RX PubMed=5788784;
RX PubMed=14505435;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Partially contaminated. Some stocks were contaminated by pig LLC-PK1 (PubMed=14505435, PubMed=20143388).
CC Discontinued: ECACC; 90112605; true.
CC Discontinued: KCLB; 10124; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 9,12
ST D5S818: 9,13
ST D7S820: 9,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AmE-711
AC CVCL_2H47
SY AME-711
RX PubMed=23894551;
WW https://beeinformed.org/2013/11/18/new-cell-cultures-advance-honey-bee-science/
CC Group: Insect cell line.
CC Doubling time: ~4 days (PubMed=23894551).
OX NCBI_TaxID=7460; ! Apis mellifera
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AMI005AN
AC CVCL_F547
SY TER202; TER271
DR IMGT/HLA; 11803
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AMJ13
AC CVCL_4U92
RX PubMed=26300657;
CC Doubling time: 22 hours (PubMed=26300657).
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AMJ2-C10
AC CVCL_0P77
RX PubMed=1879973;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID AMJ2-C11
AC CVCL_5913
DR CLO; CLO_0001714
DR ATCC; CRL-2456
DR BCRJ; 0039
RX PubMed=1879973;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID AMJ2-C20
AC CVCL_0P78
RX PubMed=1879973;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID AMJ2-C8
AC CVCL_5914
DR CLO; CLO_0001715
DR ATCC; CRL-2455
RX PubMed=1879973;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID AML-1
AC CVCL_S481
RX PubMed=3496132;
DI NCIt; C9160; Childhood acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AML-193
AC CVCL_1071
SY AML193
DR CLO; CLO_0001718
DR CLDB; cl272
DR ATCC; CRL-9589
DR ATCC; HTB-188
DR BCRJ; 0040
DR BioSample; SAMN01821616
DR BioSample; SAMN03471219
DR CCLE; AML193_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 724816
DR Cosmic; 787420
DR Cosmic; 949089
DR Cosmic; 975238
DR Cosmic; 1012057
DR Cosmic; 1281305
DR Cosmic; 2306199
DR DSMZ; ACC-549
DR GEO; GSM886867
DR GEO; GSM887932
RX PubMed=2015403;
RX PubMed=2656885;
RX PubMed=3496132;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25984343;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=AML-193
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Characteristics: CSF2 and IL3 dependent.
CC Doubling time: 65 hours (PubMed=25984343); ~50-60 hours (DSMZ).
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: BCRJ; 0040; probable.
CC Discontinued: ATCC; HTB-188; true.
ST Source(s): ATCC; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D5S818: 9,13
ST D7S820: 9,12
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C9160; Childhood acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AML12
AC CVCL_0140
SY AML-12; AML 12; Alpha Mouse Liver 12
DR BTO; BTO:0003449
DR CLO; CLO_0001716
DR MCCL; MCC:0000033
DR ATCC; CRL-2254
DR BCRC; 60326
DR BCRJ; 0354
DR GEO; GSE87156
DR GEO; GSM294842
DR GEO; GSM296415
DR GEO; GSM296416
DR GEO; GSM296417
DR GEO; GSM1374079
DR GEO; GSM1374080
DR GEO; GSM1374081
DR GEO; GSM1374082
DR GEO; GSM1374083
DR GEO; GSM1374084
DR IZSLER; BS CL 161
RX PubMed=7904757;
CC Characteristics: Produced in a transgenic mouse expressing human TGFA.
CC Doubling time: 37 hours (PubMed=7904757).
CC Omics: Transcriptome analysis.
CC Breed/subspecies: CD-1 MT42 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID AML14 [Human leukemia]
AC CVCL_8286
DR Cosmic; 975237
DR Cosmic; 1281304
RX PubMed=8443379;
RX PubMed=9474744;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AML14 [Mouse liver]
AC CVCL_K234
SY AML-14; AML 14; Alpha Mouse Liver 14
RX PubMed=7904757;
CC Characteristics: Produced in a transgenic mouse expressing human TGFA.
CC Doubling time: 32 hours (PubMed=7904757).
CC Breed/subspecies: CD-1 MT42 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID AML14.3D10
AC CVCL_0141
SY AML14-3D10; AML143D10
DR MCCL; MCC:0000034
DR GEO; GSM1374391
RX PubMed=9474744;
CC Omics: Transcriptome analysis.
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8286 ! AML14 [Human leukemia]
SX Male
CA Cancer cell line
//
ID AML14.3D10/CCCKR3 Clone 16
AC CVCL_6337
DR CLO; CLO_0001717
DR ATCC; CRL-12079
DR BioSample; SAMN03471345
CC Transfected with: HGNC; 1604; CCR3.
CC Discontinued: ATCC; CRL-12079; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 12
ST D16S539: 9,12
ST D5S818: 10,11
ST D7S820: 10,14
ST TH01: 9,9.3
ST TPOX: 9,11
ST vWA: 18,19
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0141 ! AML14.3D10
SX Male
CA Cancer cell line
//
ID AMN iPSC-3
AC CVCL_B941
DR ISCR; 1801
RX PubMed=21721033;
CC From: Yonsei University College of Medicine; Seoul; South Korea.
DI NCIt; C61252; Adrenoleukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID AMO1
AC CVCL_1806
SY AMo1; AMO-1
DR EFO; EFO_0006534
DR BioSample; SAMN03473529
DR BioSample; SAMN03472930
DR CCLE; AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CGH-DB; 9156-4
DR Cosmic; 1483074
DR Cosmic; 1889514
DR Cosmic; 2131561
DR Cosmic; 2391800
DR Cosmic-CLP; 1295741
DR DSMZ; ACC-538
DR GDSC; 1295741
DR GEO; GSM143353
DR GEO; GSM290285
DR GEO; GSM886868
DR GEO; GSM887933
DR GEO; GSM1374392
DR GEO; GSM1669599
RX PubMed=8426482;
RX PubMed=9738977;
RX PubMed=10936422;
RX PubMed=11429052;
RX PubMed=12886255;
RX PubMed=15215163;
RX PubMed=18700954;
RX PubMed=17171682;
RX PubMed=19306352;
RX PubMed=21173094;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~70-90 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9,13
ST D18S51: 15,18
ST D21S11: 30,33.2
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 13,15
ST FGA: 19,24
ST Penta D: 9,15
ST Penta E: 11
ST TH01: 7,9
ST TPOX: 8,9 (Cosmic-CLP; DSMZ)
ST TPOX: 8 (PubMed=25877200)
ST vWA: 17,18
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AMOC-2
AC CVCL_C830
SY AMOC2
RX PubMed=2794621;
RX PubMed=9433040;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AMOC-2 Subclone #10
AC CVCL_AT98
RX PubMed=9433040;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C830 ! AMOC-2
SX Female
CA Cancer cell line
//
ID AMOC-2 Subclone #11
AC CVCL_AT99
RX PubMed=9433040;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C830 ! AMOC-2
SX Female
CA Cancer cell line
//
ID AMOC-2 Subclone #2
AC CVCL_AT95
RX PubMed=9433040;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C830 ! AMOC-2
SX Female
CA Cancer cell line
//
ID AMOC-2 Subclone #4
AC CVCL_AT96
RX PubMed=9433040;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C830 ! AMOC-2
SX Female
CA Cancer cell line
//
ID AMOC-2 Subclone #6
AC CVCL_AT97
RX PubMed=9433040;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C830 ! AMOC-2
SX Female
CA Cancer cell line
//
ID AMOS-III
AC CVCL_0E45
SY AII MS Oral Squamous cell carcinoma-III
RX Patent=US6730514;
RX PubMed=13679204;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ampli-GPE
AC CVCL_4104
DR CLO; CLO_0001719
DR CLDB; cl273
DR ECACC; 95050229
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID AMR10
AC CVCL_U845
RX PubMed=7734848;
CC Monoclonal antibody target: ChEBI; CHEBI:27499; Ganglioside GM4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID AMR19
AC CVCL_U831
DR CLO; CLO_0050334
DR RCB; RCB2016
RX PubMed=8026889;
CC Monoclonal antibody target: Ganglioside GD3-lactone (GD3-L).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID AMR20
AC CVCL_U832
DR CLO; CLO_0050341
DR RCB; RCB2041
CC Monoclonal antibody target: ChEBI; CHEBI:36498; Galactosylceramide (GalCer).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID AMR38
AC CVCL_U833
RX PubMed=8026889;
CC Monoclonal antibody target: Ganglioside GM1-lactone (GM1-L).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID AMR40
AC CVCL_U834
RX PubMed=8026889;
CC Monoclonal antibody target: Ganglioside GD1a-lactone (GD1a-L).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID AMS 9.1.1.1
AC CVCL_K123
DR CLO; CLO_0001720
DR ATCC; HB-161
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AMS3
AC CVCL_H629
RX PubMed=8183550;
RX PubMed=15356658;
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Amsalem
AC CVCL_B386
DR ATCC; CRL-2628
RX PubMed=2981779;
CC Discontinued: ATCC; CRL-2628; true.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AMU-AML1
AC CVCL_M584
RX PubMed=21965128;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AMU-ML1
AC CVCL_M583
RX CelloPub=CLPUB00017;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID An Bay
AC CVCL_U667
DR ATCC; CRL-1256
CC Discontinued: ATCC; CRL-1256; true.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID An Na
AC CVCL_U766
DR ATCC; CRL-1183
CC Discontinued: ATCC; CRL-1183; true.
DI NCIt; C125701; Ehlers-Danlos syndrome, type VII
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID An Zan
AC CVCL_3644
DR CLO; CLO_0001721
DR ATCC; CRL-1266
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AN3-CA
AC CVCL_0028
SY AN3 CA; AN3 Ca; AN3CA; AN-3; AN3
DR BTO; BTO:0001771
DR CLO; CLO_0001722
DR EFO; EFO_0002110
DR ATCC; HTB-111
DR BCRJ; 0363
DR BioSample; SAMN03471092
DR BioSample; SAMN03473131
DR BioSample; SAMN03473336
DR CCLE; AN3CA_ENDOMETRIUM
DR CCRID; 3142C0001000000098
DR ChEMBL-Cells; CHEMBL3308708
DR ChEMBL-Targets; CHEMBL1075392
DR CLS; 300119/p494_AN3_Ca
DR Cosmic; 687550
DR Cosmic; 699283
DR Cosmic; 713473
DR Cosmic; 713495
DR Cosmic; 809134
DR Cosmic; 846176
DR Cosmic; 871551
DR Cosmic; 889116
DR Cosmic; 910781
DR Cosmic; 980634
DR Cosmic; 1007162
DR Cosmic; 1057760
DR Cosmic; 1066221
DR Cosmic; 1070810
DR Cosmic; 1102376
DR Cosmic; 1105620
DR Cosmic; 1177683
DR Cosmic; 1223484
DR Cosmic; 1434192
DR Cosmic; 1576450
DR Cosmic; 1622894
DR Cosmic; 1696752
DR Cosmic; 2030460
DR Cosmic-CLP; 910781
DR DSMZ; ACC-267
DR GDSC; 910781
DR GEO; GSM374970
DR GEO; GSM375429
DR GEO; GSM827494
DR GEO; GSM886869
DR GEO; GSM887934
DR GEO; GSM1669600
DR IGRhCellID; AN3CA
DR IZSLER; BS TCL 200
DR TOKU-E; 543
RX PubMed=327080;
RX PubMed=14207855;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.proteinatlas.org/learn/cellines
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC Part of: MD Anderson Cell Lines Project.
CC Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC Doubling time: ~55 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,14,15 (ATCC; CLS; Cosmic-CLP; PubMed=25877200)
ST CSF1PO: 12,14 (DSMZ)
ST D13S317: 12,14
ST D16S539: 10,14 (ATCC; CLS; DSMZ; PubMed=25877200)
ST D16S539: 10,14,15 (Cosmic-CLP)
ST D18S51: 15,18
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 11,14
ST D7S820: 7,7.1,10 (ATCC; PubMed=25877200)
ST D7S820: 7,10 (CLS; Cosmic-CLP)
ST D7S820: 7.1,10 (DSMZ)
ST D8S1179: 12,14
ST FGA: 23
ST Penta D: 9,11
ST Penta E: 9,16
ST TH01: 9.3,10
ST TPOX: 8,10
ST vWA: 14,20
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AN4;11
AC CVCL_AY52
SY AN4-11
DR Cosmic; 2393013
RX PubMed=8353274;
RX PubMed=8358709;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ANA-1
AC CVCL_0142
SY Ana-1; ANA1
DR BTO; BTO:0002775
DR MCCL; MCC:0000035
DR CCRID; 3131C0001000300002
DR KCB; KCB 200784YJ
RX PubMed=2778838;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Ana-104
AC CVCL_Z534
SY Ana 104; Ana104
RX CelloPub=CLPUB00189;
RX CelloPub=CLPUB00190;
RX DOI=10.3969/j.issn.1673-5234.2000.04.020;
CC Group: Insect cell line.
OX NCBI_TaxID=74872; ! Anopheles anthropophagus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ANBL-6
AC CVCL_5425
SY ANBL6
DR Cosmic; 720790
DR Cosmic; 1170891
DR Cosmic; 2081377
DR Cosmic; 2367285
RX PubMed=8221668;
RX PubMed=8943038;
RX PubMed=10583232;
RX PubMed=10936422;
RX PubMed=16956823;
RX PubMed=21173094;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=ANBL-6
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M523 ! ANBM-6
SX Female
CA Cancer cell line
//
ID ANBM-6
AC CVCL_M523
SY ANBM6
RX PubMed=9022078;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5425 ! ANBL-6
SX Female
CA Cancer cell line
//
ID AND-1
AC CVCL_B526
SY AND1; ESe029-A
DR BioSamples; SAMEA7772668
DR hPSCreg; ESe029-A
DR ISCR; 1635
RX PubMed=19401322;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/AND-1.pdf
CC From: Andalusian Stem Cell Bank; Granada; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID AND-1 FLT3 D835
AC CVCL_V161
SY AND1-FLT3 D835; AND-1 FLT3-TKD; AND1-FLT3 TKD
DR ISCR; 2204
RX PubMed=23479570;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier-AND1-FLT3-D835.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B526 ! AND-1
SX Male
CA Embryonic stem cell
//
ID AND-1 FLT3 ITD
AC CVCL_V160
SY AND-1 FLT3-ITD; AND1-FLT3 ITD
DR ISCR; 2203
RX PubMed=23479570;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier_AND1-FLT3-ITD.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B526 ! AND-1
SX Male
CA Embryonic stem cell
//
ID AND-1 MLLAF4
AC CVCL_V162
SY AND-1-MLLAF4; AND1-MLLAF4
DR ISCR; 2205
RX PubMed=23479570;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier-AND1-MLLAF4.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B526 ! AND-1
SX Male
CA Embryonic stem cell
//
ID AND-1 MLLAF4 FLT3 D835
AC CVCL_V163
SY AND1-MLLAF4 FLT3 D835; AND1-MLLAF4/FLT3-TKD
DR ISCR; 2206
RX PubMed=23479570;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier-AND1-MLLAF4-FLT3-D835.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B526 ! AND-1
SX Male
CA Embryonic stem cell
//
ID AND-1 MLLAF4 FLT3 ITD
AC CVCL_V164
SY AND1-MLLAF4 FLT3 ITD; AND1-MLLAF4/FLT3-ITD
DR ISCR; 2207
RX PubMed=23479570;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier_AND1-MLLAF4-FLT3-ITD.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B526 ! AND-1
SX Male
CA Embryonic stem cell
//
ID AND-1 WASKO C1.1
AC CVCL_V158
DR ISCR; 2201
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud-Deposito-Lineas-Celulares-AND-1-WASKO-C1-1.pdf
CC Knockout cell: Method=ZFN; HGNC; 12731; WAS.
DI NCIt; C3448; Wiskott-Aldrich syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B526 ! AND-1
SX Male
CA Embryonic stem cell
//
ID AND-1 WASKO C1.2
AC CVCL_V159
DR ISCR; 2202
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud-Deposito-Lineas-Celulares-AND-1-WASKO-C1-2.pdf
CC Knockout cell: Method=ZFN; HGNC; 12731; WAS.
DI NCIt; C3448; Wiskott-Aldrich syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B526 ! AND-1
SX Male
CA Embryonic stem cell
//
ID AND-2
AC CVCL_B527
SY AND2
DR ISCR; 1636
RX PubMed=19401322;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/AND-2.pdf
CC From: Andalusian Stem Cell Bank; Granada; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID AND-3
AC CVCL_B528
SY AND3
DR ISCR; 1637
RX PubMed=19401322;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/AND-3.pdf
CC From: Andalusian Stem Cell Bank; Granada; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID ANDP
AC CVCL_F823
DR IMGT/HLA; 10250
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ANE58
AC CVCL_Z178
SY ANE 58; ANE 64
DR TCB; 3071
RX PubMed=2766897;
RX PubMed=6644089;
RX PubMed=17662657;
RX PubMed=22743047;
RX PubMed=23140894;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC Group: Tick cell line.
CC Miscellaneous: Called ANE 64 in the original publication (PubMed=6644089), but seems to have been called ANE58/ANE 58 since in all other publications from the same authors.
OX NCBI_TaxID=60253; ! Dermacentor nitens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Anglne
AC CVCL_U287
DR CCRID; 3142C0001000000049
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ANGM-CSS
AC CVCL_2297
DR ECACC; 08040401
RX PubMed=24366606;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Angu-BL
AC CVCL_7173
SY Angu
RX PubMed=9882297;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Anip-973
AC CVCL_6879
SY Anip 973; ANIP 973; Anip[973]; Anip973; ANIP973
RX PubMed=14989933;
RX PubMed=20723345;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6878 ! AGZY83-a
CA Cancer cell line
//
ID Anip973/CDDP
AC CVCL_W193
RX PubMed=20723345;
RX PubMed=20738915;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6879 ! Anip-973
CA Cancer cell line
//
ID Anip973/NVB
AC CVCL_W194
SY Anip973/Navelbine
RX PubMed=17650408;
RX PubMed=20738915;
RX PubMed=22429577;
CC Selected for resistance to: ChEBI; CHEBI:480999; Vinorelbine (Navelbine; NVB).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6879 ! Anip-973
CA Cancer cell line
//
ID Anjou 65
AC CVCL_3645
SY ANJOU 65; Anjou-65
DR CLO; CLO_0001724
DR ATCC; CRL-11269
DR BioSample; SAMN03471333
DR Wikidata; Q28197162
RX Patent=WO1994019478A1;
RX PubMed=7690960;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-90.html
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12,14
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,18,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1926 ! HEK293T/17
SX Female
CA Transformed cell line
//
ID ANN-1
AC CVCL_9242
DR CLO; CLO_0001725
DR ChEMBL-Cells; CHEMBL3307385
DR ChEMBL-Targets; CHEMBL614520
RX PubMed=163444;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID ANO
AC CVCL_F533
SY TER282; TER357
DR IMGT/HLA; 12178
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Anr13-1
AC CVCL_4575
DR CLO; CLO_0050620
DR RCB; RCB0451
CC Breed/subspecies: Fischer 344/DuCrj.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4107 ! ARLJ 301-3
SX Male
CA Transformed cell line
//
ID Anr4
AC CVCL_4105
DR CLO; CLO_0001726
DR CLO; CLO_0050621
DR CLDB; cl277
DR ChEMBL-Cells; CHEMBL3308415
DR ChEMBL-Targets; CHEMBL614521
DR ECACC; 90071808
DR RCB; RCB0449
CC Breed/subspecies: Fischer 344/DuCrj.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4107 ! ARLJ 301-3
SX Male
CA Transformed cell line
//
ID Anr9-1
AC CVCL_4576
DR CLO; CLO_0050619
DR RCB; RCB0450
CC Breed/subspecies: Fischer 344/DuCrj.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4107 ! ARLJ 301-3
SX Male
CA Transformed cell line
//
ID Anso-242
AC CVCL_Z536
SY Anso 242; Anso242
RX CelloPub=CLPUB00190;
RX DOI=10.3969/j.issn.1673-5234.2000.04.020;
CC Group: Insect cell line.
OX NCBI_TaxID=74873; ! Anopheles sinensis
SX Female
CA Spontaneously immortalized cell line
//
ID anti-130-kDa Mesothelial-Ciliated Cells
AC CVCL_L580
DR CLO; CLO_0001729
DR ATCC; CRL-2401
RX PubMed=7603040;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID Anti-alpha(1)1C6F4
AC CVCL_U847
SY 1C6F4
DR CLO; CLO_0050312
DR RCB; RCB1240
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-alpha(10)10E3B7
AC CVCL_U848
SY 10E3B7
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-alpha(2)E2B5
AC CVCL_U849
SY E2B5
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-alpha(3)7E7C2
AC CVCL_U850
SY 7E7C2
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-alpha(4)11D9G5
AC CVCL_U851
SY 11D9G5
DR CLO; CLO_0050346
DR RCB; RCB1243
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-alpha(5)11D10B6
AC CVCL_U852
SY 11D10B6
DR CLO; CLO_0050347
DR RCB; RCB1244
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-alpha(6)11D10F7
AC CVCL_U853
SY 11D10F7
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-alpha(7)7C9A10
AC CVCL_U854
SY 7C9A10
DR CLO; CLO_0050344
DR RCB; RCB1246
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-alpha(8)9F3A6
AC CVCL_U855
SY 9F3A6
DR CLO; CLO_0050313
DR RCB; RCB1247
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-alpha(9)12G8B11
AC CVCL_U856
SY 12G8B11
DR CLO; CLO_0050348
DR RCB; RCB1248
RX PubMed=2544482;
CC Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID anti-alphaA-crystallin
AC CVCL_U830
DR CLO; CLO_0050315
DR RCB; RCB1303
RX PubMed=7832826;
CC Monoclonal antibody target: UniProtKB; P02504; Chicken CRYAA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID anti-alphaB-crystallin
AC CVCL_U813
DR CLO; CLO_0050304
DR RCB; RCB1304
RX PubMed=7832826;
CC Monoclonal antibody target: UniProtKB; Q05713; Chicken CRYAB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID anti-beta5-crystallin
AC CVCL_U826
DR CLO; CLO_0050305
DR RCB; RCB1305
RX PubMed=7832826;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID anti-beta6-crystallin
AC CVCL_U827
DR CLO; CLO_0050306
DR RCB; RCB1306
RX PubMed=7832826;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID anti-delta-crystallin
AC CVCL_U829
DR CLO; CLO_0050322
DR RCB; RCB1308
RX PubMed=7832826;
CC Monoclonal antibody target: UniProtKB; P02521; Chicken DLS1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID Anti-FHA(1)1C6
AC CVCL_U639
SY 1C6
DR CLO; CLO_0050394
DR RCB; RCB1239
CC Monoclonal antibody target: UniProtKB; P12255; Bordetella pertussis filamentous hemagglutinin (fhaB).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-FHA(2)2E9
AC CVCL_U640
SY 2E9
DR CLO; CLO_0050393
DR RCB; RCB1238
CC Monoclonal antibody target: UniProtKB; P12255; Bordetella pertussis filamentous hemagglutinin (fhaB).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID anti-gamma1-crystallin
AC CVCL_U828
DR CLO; CLO_0050307
DR RCB; RCB1307
RX PubMed=7832826;
CC Monoclonal antibody target: UniProtKB; Q8QFU3; Cynops pyrrhogaster gamma-crystallin.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID Anti-My-10 clone 28/8/8/14/4
AC CVCL_L094
DR CLO; CLO_0001731
DR ATCC; HB-8483
DR KCLB; 88483
RX Patent=US4714680;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S1-10D6
AC CVCL_U641
SY 10D6
DR CLO; CLO_0050358
DR RCB; RCB1208
RX PubMed=1698179;
RX PubMed=1894382;
CC Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S1-1B7
AC CVCL_U642
SY 1B7
DR CLO; CLO_0050345
DR RCB; RCB1205
RX PubMed=1698179;
RX PubMed=1894382;
RX PubMed=6094351;
CC Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S1-3F10
AC CVCL_U643
SY 3F10
DR CLO; CLO_0050402
DR RCB; RCB1212
RX PubMed=1698179;
RX PubMed=1894382;
RX PubMed=6094351;
CC Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S1-4D10
AC CVCL_U644
SY 4D10
DR CLO; CLO_0050399
DR RCB; RCB1214
RX PubMed=1698179;
RX PubMed=1894382;
CC Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S1-8G4
AC CVCL_U645
SY 8G4
DR CLO; CLO_0050359
DR RCB; RCB1209
RX PubMed=1698179;
RX PubMed=1894382;
CC Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S2-3A12
AC CVCL_U646
SY 3A12
DR CLO; CLO_0050309
DR RCB; RCB1220
RX PubMed=1894382;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S2-9G8
AC CVCL_U647
SY 9G8
DR CLO; CLO_0050401
DR RCB; RCB1222
RX PubMed=1698179;
RX PubMed=1894382;
CC Monoclonal antibody target: UniProtKB; P04978; Bordetella pertussis ptxB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S23-11E6
AC CVCL_U648
SY 11E6
DR CLO; CLO_0050308
DR RCB; RCB1215
RX PubMed=1698179;
RX PubMed=1894382;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S3-7E10
AC CVCL_U649
SY 7E10
DR CLO; CLO_0050310
DR RCB; RCB1223
RX PubMed=1698179;
RX PubMed=1894382;
CC Monoclonal antibody target: UniProtKB; P04979; Bordetella pertussis ptxC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S4-1H2
AC CVCL_U861
SY 1H2
DR CLO; CLO_0050400
DR RCB; RCB1233
RX PubMed=1894382;
CC Monoclonal antibody target: UniProtKB; P0A3R5; Bordetella pertussis ptxD.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-PT-S4-7F2
AC CVCL_U650
SY 7F2
DR CLO; CLO_0050311
DR RCB; RCB1229
RX PubMed=1894382;
CC Monoclonal antibody target: UniProtKB; P0A3R5; Bordetella pertussis ptxD.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Anti-SC35
AC CVCL_L674
DR CLO; CLO_0001732
DR ATCC; CRL-2031
DR BCRC; 60171
RX PubMed=2137203;
CC Monoclonal antibody target: UniProtKB; Q01130; Human SRSF2/SC35.
CC Misspelling: 'Anti-SSC35' in BCRC 60171.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6971 ! FOX-NY
CA Hybridoma
//
ID anti-SR
AC CVCL_G689
SY 1H4
DR CLO; CLO_0001733
DR ATCC; CRL-2383
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6971 ! FOX-NY
CA Hybridoma
//
ID anti-SRp20
AC CVCL_G690
SY 7B4
DR CLO; CLO_0001734
DR ATCC; CRL-2384
CC Monoclonal antibody target: UniProtKB; P84103; Human SRSF3.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6971 ! FOX-NY
CA Hybridoma
//
ID Anti-theta(1)3H10
AC CVCL_U857
SY 3H10
DR CLO; CLO_0050314
DR RCB; RCB1250
CC Monoclonal antibody target: UniProtKB; P0C2E9; C.perfringens pfo.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Antibody 2.06
AC CVCL_L673
DR CLO; CLO_0001730
DR ATCC; HB-104
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID AO
AC CVCL_D631
DR BioSample; SAMN03151664
RX PubMed=1246601;
RX PubMed=4128382;
RX PubMed=4472134;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=4472134, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID Ao/I
AC CVCL_AV09
RX PubMed=26820856;
CC Group: Insect cell line.
OX NCBI_TaxID=480707; ! Adoxophyes orana
SX Female
CA Spontaneously immortalized cell line
//
ID AO2V4
AC CVCL_Z597
RX PubMed=8943096;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8567 ! SK-AO2
SX Male
CA Cancer cell line
//
ID AOK-B50
AC CVCL_8171
DR BTO; BTO:0003851
RX PubMed=8386606;
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0391 ! LLC-PK1
SX Male
CA Spontaneously immortalized cell line
//
ID AOTO
AC CVCL_F643
RX PubMed=15767549;
CC Part of: JFCR45 cancer cell line panel.
CC From: Kawaguchi T.; Department of Pathology; Cancer Institute, Japanese Foundation for Cancer Research; Tokyo; Japan.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AP
AC CVCL_E457
DR dbMHC; 48475
DR IHW; IHW9229
DR IMGT/HLA; 10251
WW http://bioinformatics.hsanmartino.it/ecbr/cl229.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID AP-1
AC CVCL_HF85
RX PubMed=25137137;
CC Doubling time: 3.342 days (PubMed=25137137).
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AP-1 LUCPorter
AC CVCL_W339
SY AP-1 LUCPorter stable reporter cell line
CC Transfected with: UniProtKB; P27652; Renilla-type luciferase.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID AP-1060
AC CVCL_1807
DR BioSample; SAMN03473492
DR DSMZ; ACC-593
RX PubMed=15116119;
CC Doubling time: ~80-100 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AP-16
AC CVCL_5432
DR IFO; IFO50424
RX PubMed=8391585;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=AP-16
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID AP-18
AC CVCL_X041
RX PubMed=16210832;
RX PubMed=19947910;
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID AP-217
AC CVCL_A052
DR Cosmic; 1012058
RX PubMed=9279364;
RX PubMed=16408098;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AP-3
AC CVCL_J157
DR CLO; CLO_0001736
DR ATCC; HB-242
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID AP-64
AC CVCL_Z826
RX PubMed=9768180;
CC Group: Insect cell line.
OX NCBI_TaxID=316597; ! Aedes pseudoscutellaris
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AP.6
AC CVCL_G634
DR CLO; CLO_0001735
DR ATCC; CRL-2227
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID AP106
AC CVCL_F534
DR IMGT/HLA; 10252
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AP109
AC CVCL_F535
DR IMGT/HLA; 10253
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AP110
AC CVCL_F536
DR IMGT/HLA; 10254
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AP115
AC CVCL_F537
DR IMGT/HLA; 10255
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AP2
AC CVCL_W419
RX PubMed=9230912;
DI NCIt; C4650; Parotid gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AP630
AC CVCL_F538
SY TER199; TER292
DR IMGT/HLA; 10256
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AP7P
AC CVCL_J287
DR BioSample; SAMN03472407
DR JCRB; JCRB3011
DR JCRB; KURB1401
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 8,9
ST D16S539: 10,11
ST D5S818: 10
ST D7S820: 10,12
ST TH01: 9,10
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AP7P(SVT)
AC CVCL_L454
DR JCRB; KURB1402
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C125702; Fanconi anemia, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J287 ! AP7P
SX Female
CA Transformed cell line
//
ID APA
AC CVCL_E458
SY TER61; TER224; TER258; TER452
DR dbMHC; 48476
DR ECACC; 94022522
DR IHW; IHW9237
DR IMGT/HLA; 10257
WW http://bioinformatics.hsanmartino.it/ecbr/cl237.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID APD
AC CVCL_E459
SY GM06817
DR CLO; CLO_0036534
DR Coriell; GM06817
DR dbMHC; 48477
DR ECACC; 94071427
DR IHW; IHW9291
DR IMGT/HLA; 10258
RX PubMed=6417008;
WW http://bioinformatics.hsanmartino.it/ecbr/cl291.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID APE1
AC CVCL_Z272
RX PubMed=8907121;
CC Group: Insect cell line.
OX NCBI_TaxID=247271; ! Antitrogus parvulus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID APHL1
AC CVCL_Z273
RX PubMed=8907121;
CC Group: Insect cell line.
OX NCBI_TaxID=247271; ! Antitrogus parvulus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AQ
AC CVCL_M613
DR Cosmic; 848245
RX PubMed=10632461;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ar Bo
AC CVCL_U767
DR ATCC; CRL-1272
CC Discontinued: ATCC; CRL-1272; true.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Ar Ke-2
AC CVCL_3646
DR CLO; CLO_0001739
DR ATCC; CRL-1324
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Ar Lip
AC CVCL_Y115
DR ATCC; CRL-1233
CC Discontinued: ATCC; CRL-1233; true.
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Ar Mor
AC CVCL_U768
DR ATCC; CRL-1221
RX PubMed=3860870;
CC Discontinued: ATCC; CRL-1221; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Ar-13
AC CVCL_0I23
RX PubMed=25761724;
CC Group: Insect cell line.
CC Doubling time: 3 days (PubMed=25761724).
OX NCBI_TaxID=124917; ! Armigeres subalbatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Ar-3
AC CVCL_0I24
RX PubMed=25761724;
CC Group: Insect cell line.
CC Doubling time: 2.7 days (PubMed=25761724).
OX NCBI_TaxID=124917; ! Armigeres subalbatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AR-5
AC CVCL_F824
RX PubMed=9886832;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID AR-C40
AC CVCL_8172
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0391 ! LLC-PK1
SX Male
CA Spontaneously immortalized cell line
//
ID AR-EcoScreen
AC CVCL_8544
DR JCRB; JCRB1328
RX PubMed=15110108;
RX PubMed=15713541;
CC Transfected with: HGNC; 644; AR.
CC Transfected with: UniProtKB; P27652; Renilla-type luciferase.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID AR230
AC CVCL_9478
SY AR-230
DR Cosmic; 787490
DR Cosmic; 1026575
DR Cosmic; 2364007
RX PubMed=7606740;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AR230-r
AC CVCL_DP56
RX PubMed=10910924;
CC Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9478 ! AR230
SX Female
CA Cancer cell line
//
ID AR230-rn
AC CVCL_DP53
RX PubMed=19047160;
CC Selected for resistance to: ChEBI; CHEBI:52172; Nilotinib (AMN107; Tasigna).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9478 ! AR230
SX Female
CA Cancer cell line
//
ID AR42J
AC CVCL_0143
SY AR4-2J; AR-42J
DR BTO; BTO:0001928
DR CLO; CLO_0001740
DR MCCL; MCC:0000036
DR CLDB; cl280
DR CLDB; cl281
DR ATCC; CRL-1492
DR BCRC; 60160
DR CCRID; 3131C0001001000006
DR CCRID; 3142C0001000000134
DR ChEMBL-Cells; CHEMBL3307902
DR ChEMBL-Targets; CHEMBL614271
DR CLS; 500478/p744_AR42J
DR ECACC; 93100618
DR TOKU-E; 555
RX CelloPub=CLPUB00018;
RX PubMed=7517639;
RX PubMed=17392489;
WW http://www.addexbio.com/productdetail?pid=24
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-364.html
CC Breed/subspecies: Wistar.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID AR42J-B13
AC CVCL_0E02
SY AR42J-B-13; B-13
RX PubMed=8756573;
RX PubMed=20685382;
CC Breed/subspecies: Wistar.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0143 ! AR42J
CA Cancer cell line
//
ID ARA
AC CVCL_F548
SY TER157; TER219; TER281
DR IMGT/HLA; 10260
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ARA-10
AC CVCL_A053
SY Ara-10; ARA 10; ARA10
DR Cosmic; 801734
RX PubMed=6582512;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ARA016
AC CVCL_F539
SY TER324
DR IMGT/HLA; 10261
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ARAC-8C
AC CVCL_GZ09
SY CCRF-CEM-AraC-8C; CEM/ARAC-8C; AraC-8C; Ara-C/8C
DR TOKU-E; 4127
RX PubMed=2842332;
RX PubMed=18279955;
WW http://icoregon.technologypublisher.com/technology/18057
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID ARAC-8D
AC CVCL_GZ10
SY CCRF-CEM-AraC-8D; CEM-AraC-8D; AraC-8D; Ara-C/8D
RX PubMed=2842332;
RX PubMed=18279955;
WW http://icoregon.technologypublisher.com/technology/18059
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID ARAC25
AC CVCL_F540
DR IMGT/HLA; 10262
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Aramis
AC CVCL_M600
SY ARAMIS
RX PubMed=12193296;
RX PubMed=15320967;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ARBO
AC CVCL_E460
DR dbMHC; 48478
DR IHW; IHW9102
DR IMGT/HLA; 11614
WW http://bioinformatics.hsanmartino.it/ecbr/cl102.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID ARBO C11
AC CVCL_8832
RX PubMed=638021;
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_8833 ! ARBO C9
CA Finite cell line
//
ID ARBO C9
AC CVCL_8833
RX PubMed=638021;
RX PubMed=7190976;
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_8832 ! ARBO C11
CA Finite cell line
//
ID ARCaP
AC CVCL_4830
SY MDA PCa 1
DR TOKU-E; 4101
RX PubMed=8986779;
RX PubMed=12725112;
RX PubMed=14518029;
WW http://capcelllines.ca/details.asp?id=85
CC Derived from metastatic site: Ascites.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AREc32
AC CVCL_1D32
DR Ximbio; 151014
RX PubMed=17108137;
WW http://www.cxrbiosciences.com/technologies/arec32-cell-line/
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0031 ! MCF-7
SX Female
CA Cancer cell line
//
ID ARH-77
AC CVCL_1072
SY ARH 77; ARH77
DR BTO; BTO:0002992
DR CLO; CLO_0001744
DR CLO; CLO_0001745
DR EFO; EFO_0002111
DR CLDB; cl285
DR ATCC; CRL-1621
DR BCRC; 60385
DR BioSample; SAMN03471407
DR ChEMBL-Cells; CHEMBL3308536
DR ChEMBL-Targets; CHEMBL2366241
DR Cosmic; 759914
DR Cosmic; 886086
DR Cosmic; 888020
DR Cosmic; 906765
DR Cosmic; 919148
DR Cosmic; 999792
DR Cosmic-CLP; 906765
DR DSMZ; ACC-512
DR ECACC; 88121201
DR GDSC; 906765
DR GEO; GSM1374393
DR GEO; GSM1669601
DR IGRhCellID; ARH77
DR Lonza; 593
RX PubMed=566614;
RX PubMed=7579375;
RX PubMed=10516762;
RX PubMed=10936422;
RX PubMed=27397505;
CC Problematic cell line: Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=7579375, PubMed=10516762).
CC Doubling time: 110.4 hours (PubMed=566614); ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'AHR 77'.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC
ST Amelogenin: X
ST CSF1PO: 6,10
ST D13S317: 11,13
ST D16S539: 9,13
ST D5S818: 10,13
ST D7S820: 7,12
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ARH-DR
AC CVCL_W396
RX CelloPub=CLPUB00019;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ARIP
AC CVCL_3488
AS CVCL_7243
SY AR41P; AR4IP
DR CLO; CLO_0001741
DR CLO; CLO_0001746
DR CLDB; cl282
DR ATCC; CRL-1674
DR ChEMBL-Cells; CHEMBL3308355
DR ChEMBL-Targets; CHEMBL613534
DR TOKU-E; 557
RX CelloPub=CLPUB00018;
CC Breed/subspecies: Wistar.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID ARIP/PDX-1
AC CVCL_S556
RX PubMed=11249068;
CC Transfected with: RGD; 62387; Pdx1.
CC Breed/subspecies: Wistar.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3488 ! ARIP
CA Cancer cell line
//
ID ARK
AC CVCL_A760
SY Ark; ark; ARK-B
DR BTO; BTO:0003930
DR Cosmic; 720774
DR Cosmic; 760398
DR Cosmic; 2302413
DR Cosmic; 2367270
RX PubMed=8427968;
RX PubMed=8943038;
RX PubMed=10936422;
RX PubMed=11167840;
RX PubMed=15381930;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ARL-14
AC CVCL_4Z19
SY ARL 14; Adult Rat Liver-14
RX PubMed=427743;
RX PubMed=2903442;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Finite cell line
//
ID ARL-15
AC CVCL_0D75
SY ARL 15; Adult Rat Liver-15
RX PubMed=40692;
RX PubMed=427743;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Finite cell line
//
ID ARL-15C1
AC CVCL_0D77
DR BTO; BTO:0005448
RX PubMed=2870063;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0D75 ! ARL-15
SX Male
CA Finite cell line
//
ID ARL-16
AC CVCL_0D76
SY ARL 16; Adult Rat Liver-16
RX PubMed=40692;
RX PubMed=427743;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Finite cell line
//
ID ARL-16T2
AC CVCL_0D78
DR BTO; BTO:0005449
RX PubMed=2870063;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0D76 ! ARL-16
SX Male
CA Transformed cell line
//
ID ARL-18
AC CVCL_4Z20
SY ARL 18; Adult Rat Liver-18
RX PubMed=427743;
RX PubMed=2903442;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Finite cell line
//
ID ARL-19
AC CVCL_4Z21
SY ARL 19; Adult Rat Liver-19
RX PubMed=2903442;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Finite cell line
//
ID ARL-6
AC CVCL_4106
SY ARL 6; Adult Rat Liver-6
DR CLO; CLO_0001747
DR CLDB; cl286
DR ECACC; 87050701
RX PubMed=40692;
RX PubMed=427743;
RX PubMed=2903442;
RX PubMed=4373256;
CC Breed/subspecies: Wistar.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID ARLJ 301-3
AC CVCL_4107
SY ARLJ301-3
DR CLO; CLO_0050623
DR CLO; CLO_0001748
DR CLDB; cl287
DR ECACC; 90071806
DR JCRB; JCRB0248
DR RCB; RCB0447
RX CelloPub=CLPUB00160;
CC Breed/subspecies: Fischer 344/DuCrj.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID ARLJ 301-3TR1
AC CVCL_5243
SY ARLJ301-3TR1
DR CLO; CLO_0050622
DR RCB; RCB0448
CC Breed/subspecies: Fischer 344/DuCrj.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4107 ! ARLJ 301-3
SX Male
CA Transformed cell line
//
ID ARM-C
AC CVCL_IW83
RX PubMed=23372829;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IW84 ! ARM-E
OI CVCL_IW85 ! ARM-G
OI CVCL_IW86 ! ARM-H
OI CVCL_IW87 ! ARM-X
SX Female
CA Cancer cell line
//
ID ARM-E
AC CVCL_IW84
RX PubMed=23372829;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IW83 ! ARM-C
OI CVCL_IW85 ! ARM-G
OI CVCL_IW86 ! ARM-H
OI CVCL_IW87 ! ARM-X
SX Female
CA Cancer cell line
//
ID ARM-G
AC CVCL_IW85
RX PubMed=23372829;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IW83 ! ARM-C
OI CVCL_IW84 ! ARM-E
OI CVCL_IW86 ! ARM-H
OI CVCL_IW87 ! ARM-X
SX Female
CA Cancer cell line
//
ID ARM-H
AC CVCL_IW86
RX PubMed=23372829;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IW83 ! ARM-C
OI CVCL_IW84 ! ARM-E
OI CVCL_IW85 ! ARM-G
OI CVCL_IW87 ! ARM-X
SX Female
CA Cancer cell line
//
ID ARM-X
AC CVCL_IW87
RX PubMed=23372829;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IW83 ! ARM-C
OI CVCL_IW84 ! ARM-E
OI CVCL_IW85 ! ARM-G
OI CVCL_IW86 ! ARM-H
SX Female
CA Cancer cell line
//
ID ARM193
AC CVCL_B992
DR CLO; CLO_0050317
DR RCB; RCB0002
CC Monoclonal antibody target: UniProtKB; P0A7G6; Escherichia coli recA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID ARM321
AC CVCL_B993
DR CLO; CLO_0050290
DR RCB; RCB0115
CC Monoclonal antibody target: UniProtKB; P0A7G6; Escherichia coli recA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID ARMD1-hiPSC1
AC CVCL_B960
SY ARMD.1.H.iPSC.1
DR RSCB; RSCB0120
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B962 ! ARMD1-hiPSC2
OI CVCL_B963 ! ARMD1-hiPSC4
OI CVCL_B964 ! ARMD1-hiPSC5
OI CVCL_B965 ! ARMD1-hiPSC8
OI CVCL_B966 ! ARMD1-hiPSC9
OI CVCL_B961 ! ARMD1-hiPSC11
SX Female
CA Induced pluripotent stem cell
//
ID ARMD1-hiPSC11
AC CVCL_B961
SY ARMD.1.H.iPSC.11
DR RSCB; RSCB0126
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B960 ! ARMD1-hiPSC1
OI CVCL_B962 ! ARMD1-hiPSC2
OI CVCL_B963 ! ARMD1-hiPSC4
OI CVCL_B964 ! ARMD1-hiPSC5
OI CVCL_B965 ! ARMD1-hiPSC8
OI CVCL_B966 ! ARMD1-hiPSC9
SX Female
CA Induced pluripotent stem cell
//
ID ARMD1-hiPSC2
AC CVCL_B962
SY ARMD.1.H.iPSC.2; RIi013-A
DR hPSCreg; RIi013-A
DR RSCB; RSCB0121
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B960 ! ARMD1-hiPSC1
OI CVCL_B963 ! ARMD1-hiPSC4
OI CVCL_B964 ! ARMD1-hiPSC5
OI CVCL_B965 ! ARMD1-hiPSC8
OI CVCL_B966 ! ARMD1-hiPSC9
OI CVCL_B961 ! ARMD1-hiPSC11
SX Female
CA Induced pluripotent stem cell
//
ID ARMD1-hiPSC4
AC CVCL_B963
SY ARMD.1.H.iPSC.4
DR RSCB; RSCB0122
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B960 ! ARMD1-hiPSC1
OI CVCL_B962 ! ARMD1-hiPSC2
OI CVCL_B964 ! ARMD1-hiPSC5
OI CVCL_B965 ! ARMD1-hiPSC8
OI CVCL_B966 ! ARMD1-hiPSC9
OI CVCL_B961 ! ARMD1-hiPSC11
SX Female
CA Induced pluripotent stem cell
//
ID ARMD1-hiPSC5
AC CVCL_B964
SY ARMD.1.H.iPSC.5
DR RSCB; RSCB0123
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B960 ! ARMD1-hiPSC1
OI CVCL_B962 ! ARMD1-hiPSC2
OI CVCL_B963 ! ARMD1-hiPSC4
OI CVCL_B965 ! ARMD1-hiPSC8
OI CVCL_B966 ! ARMD1-hiPSC9
OI CVCL_B961 ! ARMD1-hiPSC11
SX Female
CA Induced pluripotent stem cell
//
ID ARMD1-hiPSC8
AC CVCL_B965
SY ARMD.1.H.iPSC.8
DR RSCB; RSCB0124
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B960 ! ARMD1-hiPSC1
OI CVCL_B962 ! ARMD1-hiPSC2
OI CVCL_B963 ! ARMD1-hiPSC4
OI CVCL_B964 ! ARMD1-hiPSC5
OI CVCL_B966 ! ARMD1-hiPSC9
OI CVCL_B961 ! ARMD1-hiPSC11
SX Female
CA Induced pluripotent stem cell
//
ID ARMD1-hiPSC9
AC CVCL_B966
SY ARMD.1.H.iPSC.9
DR RSCB; RSCB0125
CC From: Royan Institute; Theran; Iran.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B960 ! ARMD1-hiPSC1
OI CVCL_B962 ! ARMD1-hiPSC2
OI CVCL_B963 ! ARMD1-hiPSC4
OI CVCL_B964 ! ARMD1-hiPSC5
OI CVCL_B965 ! ARMD1-hiPSC8
OI CVCL_B961 ! ARMD1-hiPSC11
SX Female
CA Induced pluripotent stem cell
//
ID ARNT
AC CVCL_E461
SY ARENT; GM03153
DR CLO; CLO_0013523
DR Coriell; GM03153
DR dbMHC; 48479
DR ECACC; 94071428
DR IHW; IHW9292
DR IMGT/HLA; 10264
WW http://bioinformatics.hsanmartino.it/ecbr/cl292.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ARO
AC CVCL_0144
SY ARO 81-1; ARO81-1; ARO-81; ARO81; UCLA-RO 81; UCLA RO-81-A-1; UCLA RO-81A-1
DR BTO; BTO:0002306
DR MCCL; MCC:0000037
DR BioSample; SAMN03151786
DR BioSample; SAMN03151787
DR CGH-DB; 55-1
DR ChEMBL-Cells; CHEMBL3307996
DR ChEMBL-Targets; CHEMBL612590
DR Cosmic; 685603
DR Cosmic; 755291
DR Cosmic; 849972
DR Cosmic; 886550
DR Cosmic; 888094
DR Cosmic; 888277
DR Cosmic; 891254
DR Cosmic; 913250
DR Cosmic; 918184
DR Cosmic; 931242
DR Cosmic; 990532
DR Cosmic; 1005458
DR Cosmic; 1094760
DR Cosmic; 1152116
DR Cosmic; 1155329
DR Cosmic; 1162836
DR Cosmic; 1184761
DR Cosmic; 1699417
DR Cosmic; 2050371
DR TOKU-E; 4069
RX PubMed=16924234;
RX PubMed=18713817;
RX PubMed=20143388;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817, PubMed=20143388, PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
CC From: Juillard G.J.F.; University of California, Los Angeles; Los Angeles; USA.
ST Source(s): PubMed=18713817; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 12,13
ST D21S11: 30
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10,16
ST FGA: 20,22
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID ARP-1
AC CVCL_D523
SY ARP1; AR-P1
DR BTO; BTO:0003931
DR Cosmic; 2367264
RX PubMed=7949178;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ARPE-19
AC CVCL_0145
SY ARPE19; Adult Retinal Pigment Epithelial cell line-19; NTC-200; NTC200
DR BTO; BTO:0002335
DR CLO; CLO_0001749
DR EFO; EFO_0006271
DR MCCL; MCC:0000038
DR ATCC; CRL-2302
DR BCRC; 60383
DR BCRJ; 0041
DR BioSample; SAMN03471862
DR IZSLER; BS CL 193
DR Lonza; 871
DR Wikidata; Q28812659
RX PubMed=8698076;
RX PubMed=11504951;
RX PubMed=16262907;
RX PubMed=21697133;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-617.html
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Spontaneously immortalized cell line
//
ID ARPE-19/CNTF
AC CVCL_IQ60
SY ARPE/CNTF; ARPE-P444; NTC-201; NTC201
RX Patent=US6361771;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2524.
CC Transfected with: HGNC; 2169; CNTF.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0145 ! ARPE-19
SX Male
CA Spontaneously immortalized cell line
//
ID ARPE-19/CNTF-10
AC CVCL_IQ63
SY NTC-201-10
RX CelloPub=CLPUB00369;
CC Transfected with: HGNC; 2169; CNTF.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_IQ60 ! ARPE-19/CNTF
SX Male
CA Spontaneously immortalized cell line
//
ID ARPE-19/CNTF-6A
AC CVCL_IQ64
SY NTC-201-6A
RX CelloPub=CLPUB00369;
CC Transfected with: HGNC; 2169; CNTF.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_IQ60 ! ARPE-19/CNTF
SX Male
CA Spontaneously immortalized cell line
//
ID ARPE-19/EGFP
AC CVCL_IQ61
SY ARPE/GFP; P-393-1; NTC200p393(1)
RX Patent=US6361771;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2522.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0145 ! ARPE-19
SX Male
CA Spontaneously immortalized cell line
//
ID ARPE-19/GDNF
AC CVCL_IQ62
SY ARPE/GDNF; ARPE-19/p559; NTC200p559
RX Patent=US6361771;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2523.
CC Transfected with: HGNC; 4232; GDNF.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0145 ! ARPE-19
SX Male
CA Spontaneously immortalized cell line
//
ID ARPE-19/HPV-16
AC CVCL_6338
DR CLO; CLO_0001750
DR ATCC; CRL-2502
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0145 ! ARPE-19
SX Male
CA Transformed cell line
//
ID AS [Human neuroblastoma]
AC CVCL_S099
RX PubMed=7073944;
CC Doubling time: 35.8 hours (PubMed=7073944).
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AS [Salmon]
AC CVCL_6F68
RX DOI=10.1139/f73-152;
CC Group: Fish cell line.
OX NCBI_TaxID=8030; ! Salmo salar
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AS iPS del 1-0
AC CVCL_U498
SY ASdel1-0; AG1-0
RX PubMed=20876107;
WW https://www.kerafast.com/product/1545/angelman-syndrome-ag1-0-human-induced-pluripotent-stem-cells
DI NCIt; C75462; Angelman syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U499 ! AS iPS del 1-1
SX Female
CA Induced pluripotent stem cell
//
ID AS iPS del 1-1
AC CVCL_U499
SY ASdel1-1
RX PubMed=20876107;
DI NCIt; C75462; Angelman syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U498 ! AS iPS del 1-0
SX Female
CA Induced pluripotent stem cell
//
ID AS iPS del 2-0
AC CVCL_U500
SY ASdel2-0
RX PubMed=20876107;
DI NCIt; C75462; Angelman syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5I46 ! WG1631
SX Male
CA Induced pluripotent stem cell
//
ID AS iPS del 2-3
AC CVCL_U501
SY ASdel2-3
RX PubMed=20876107;
DI NCIt; C75462; Angelman syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5I46 ! WG1631
SX Male
CA Induced pluripotent stem cell
//
ID AS 33
AC CVCL_J975
DR CLO; CLO_0001751
DR ATCC; HB-8779
RX Patent=US5160723;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID AS-1
AC CVCL_DC71
DR ATCC; CRL-8118
RX Patent=US5024946;
RX PubMed=2470715;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-8118; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2710 ! RPMI-1788
SX Male
CA Transformed cell line
//
ID AS-D-653-TC
AC CVCL_F988
SY AS-D-653
DR TKG; TKG 0117
DR TKG; TKG 0671
CC Breed/subspecies: Donryu.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID AS-E2
AC CVCL_6769
DR Cosmic; 787421
DR Cosmic; 975239
DR Cosmic; 1012059
DR Cosmic; 1281306
DR Cosmic; 2306200
RX PubMed=9369430;
RX PubMed=16408098;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=AS-E2
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AS-H 1
AC CVCL_Z499
RX DOI=10.1080/03235409009438961;
CC Group: Insect cell line.
OX NCBI_TaxID=47767; ! Agrotis segetum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AS-H 4
AC CVCL_Z500
RX DOI=10.1080/03235409009438961;
CC Group: Insect cell line.
OX NCBI_TaxID=47767; ! Agrotis segetum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AS-M
AC CVCL_8656
RX PubMed=14741847;
DI NCIt; C4489; Skin angiosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AS-M.5
AC CVCL_8657
RX PubMed=14741847;
DI NCIt; C4489; Skin angiosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8656 ! AS-M
SX Male
CA Cancer cell line
//
ID AS034
AC CVCL_B340
SY AS 034; CEBe002-A
DR hPSCreg; CEBe002-A
DR ISCR; 59
RX PubMed=15153613;
RX PubMed=20177996;
CC From: Cellectis/Cellartis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID AS034.1
AC CVCL_B341
SY CEBe003-A
DR hPSCreg; CEBe003-A
DR ISCR; 57
RX PubMed=15153613;
RX PubMed=20177996;
CC From: Cellectis/Cellartis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B340 ! AS034
SX Male
CA Embryonic stem cell
//
ID AS034.1.1
AC CVCL_B342
SY CEBe005-A
DR hPSCreg; CEBe005-A
DR ISCR; 56
RX PubMed=20177996;
CC From: Cellectis/Cellartis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B341 ! AS034.1
SX Male
CA Embryonic stem cell
//
ID AS034.2
AC CVCL_B343
SY CEBe004-A
DR hPSCreg; CEBe004-A
DR ISCR; 58
CC From: Cellectis/Cellartis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B340 ! AS034
SX Male
CA Embryonic stem cell
//
ID AS038
AC CVCL_B344
SY AS 038; CEBe006-A
DR hPSCreg; CEBe006-A
DR ISCR; 60
RX PubMed=15153613;
RX PubMed=20177996;
CC From: Cellectis/Cellartis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID AS079
AC CVCL_B345
SY CEBe008-A
DR hPSCreg; CEBe008-A
DR ISCR; 61
CC From: Cellectis/Cellartis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID AS094
AC CVCL_B346
DR ISCR; 207
CC From: Cellectis/Cellartis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID AS17
AC CVCL_8536
DR JCRB; JCRB1392
RX PubMed=9084877;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID AS283A
AC CVCL_A761
SY As283A
DR Cosmic; 1515198
RX PubMed=1325212;
RX PubMed=2052620;
RX PubMed=8344493;
RX PubMed=8515068;
RX PubMed=9973220;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID As4.1
AC CVCL_0151
SY As41; Clone 4.1
DR CLO; CLO_0001753
DR MCCL; MCC:0000043
DR ATCC; CRL-2193
RX PubMed=2174057;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID ASAN-PaCa
AC CVCL_GP71
DR Cosmic; 2566118
RX PubMed=27518460;
CC Doubling time: 20 hours (PubMed=27518460).
CC Omics: Deep exome analysis.
DI NCIt; C38342; Pancreatic intraductal papillary-mucinous neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Asano
AC CVCL_D299
DR Cosmic; 945372
RX PubMed=8980248;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ASB-10W
AC CVCL_8626
RX PubMed=4052977;
CC Transformant: ChEBI; CHEBI:46661; Asbestos.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Female
CA Transformed cell line
//
ID ASB-410
AC CVCL_8648
RX PubMed=4052977;
CC Transformant: ChEBI; CHEBI:46661; Asbestos.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Male
CA Transformed cell line
//
ID ASB-XIII
AC CVCL_5685
SY ASB XIII
RX PubMed=6652624;
CC Transformant: ChEBI; CHEBI:46661; Asbestos.
CC Breed/subspecies: BALB/c.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID ASB-XIV
AC CVCL_5686
SY ASB XIV
DR CLS; 400120/p585_ASB-XIV
RX PubMed=6652624;
CC Transformant: ChEBI; CHEBI:46661; Asbestos.
CC Breed/subspecies: BALB/c.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID ASBB
AC CVCL_A017
SY Asian Sea Bass Brain
RX PubMed=21082288;
CC Group: Fish cell line.
OX NCBI_TaxID=8187; ! Lates calcarifer
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ASC-17D
AC CVCL_6D60
SY Adult Sertoli Cell-17 clone D
RX PubMed=8562702;
RX PubMed=15716129;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Conditionally immortalized cell line
//
ID ASC52telo
AC CVCL_U602
AS CVCL_9Q54
SY ASC/TERT1
DR ATCC; SCRC-4000
DR BioSample; SAMN03471937
RX PubMed=19125642;
WW http://www.evercyte.com/asc-tert1-91.html
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 10,13
ST D5S818: 11,13
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 8
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID ASC57telo
AC CVCL_U603
DR ATCC; SCRC-4001
DR BioSample; SAMN03471938
RX PubMed=19125642;
CC Doubling time: ~40 hours (ATCC).
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; SCRC-4001; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 8,10
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 10,11
ST D7S820: 8
ST TH01: 6
ST TPOX: 8,9
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID ASE
AC CVCL_6G15
SY Atlantic Salmon Embryo
RX CelloPub=CLPUB00103;
RX DOI=10.3147/jsfp.28.27;
CC Group: Fish cell line.
OX NCBI_TaxID=8030; ! Salmo salar
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ASF-1
AC CVCL_S925
CC Group: Fish cell line.
OX NCBI_TaxID=34773; ! Alosa sapidissima
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ASF-4-1
AC CVCL_2854
DR BioSample; SAMN03472790
DR IFO; IFO50418
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 9,10
ST D7S820: 10,11
ST TH01: 8,9
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2855 ! ASF-4-2
OI CVCL_8497 ! ASF-4-3L
OI CVCL_8498 ! ASF-4-4L1
OI CVCL_8499 ! ASF-4-4L2
OI CVCL_8500 ! ASF-4-4R2
SX Male
CA Finite cell line
//
ID ASF-4-2
AC CVCL_2855
DR IFO; IFO50419
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 9,10
ST D7S820: 10,11
ST TH01: 8,9
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2854 ! ASF-4-1
OI CVCL_8497 ! ASF-4-3L
OI CVCL_8498 ! ASF-4-4L1
OI CVCL_8499 ! ASF-4-4L2
OI CVCL_8500 ! ASF-4-4R2
SX Male
CA Finite cell line
//
ID ASF-4-3L
AC CVCL_8497
DR JCRB; JCRB1431
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 9,10
ST D7S820: 10,11
ST TH01: 8,9
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2854 ! ASF-4-1
OI CVCL_2855 ! ASF-4-2
OI CVCL_8498 ! ASF-4-4L1
OI CVCL_8499 ! ASF-4-4L2
OI CVCL_8500 ! ASF-4-4R2
SX Male
CA Finite cell line
//
ID ASF-4-4L1
AC CVCL_8498
DR JCRB; JCRB1441
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 9,10
ST D7S820: 10,11
ST TH01: 8,9
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2854 ! ASF-4-1
OI CVCL_2855 ! ASF-4-2
OI CVCL_8497 ! ASF-4-3L
OI CVCL_8499 ! ASF-4-4L2
OI CVCL_8500 ! ASF-4-4R2
SX Male
CA Finite cell line
//
ID ASF-4-4L2
AC CVCL_8499
DR JCRB; JCRB1442
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 9,10
ST D7S820: 10,11
ST TH01: 8,9
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2854 ! ASF-4-1
OI CVCL_2855 ! ASF-4-2
OI CVCL_8497 ! ASF-4-3L
OI CVCL_8498 ! ASF-4-4L1
OI CVCL_8500 ! ASF-4-4R2
SX Male
CA Finite cell line
//
ID ASF-4-4R2
AC CVCL_8500
DR JCRB; JCRB1446
CC Discontinued: JCRB; JCRB1446; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2854 ! ASF-4-1
OI CVCL_2855 ! ASF-4-2
OI CVCL_8497 ! ASF-4-3L
OI CVCL_8498 ! ASF-4-4L1
OI CVCL_8499 ! ASF-4-4L2
SX Male
CA Finite cell line
//
ID ASH
AC CVCL_R966
SY Atlantic Salmon Heart
RX PubMed=6767657;
CC Group: Fish cell line.
CC From: Gillespie J.H.; Cornell University College of Veterinary Medicine; Ithaca; USA.
OX NCBI_TaxID=8030; ! Salmo salar
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ASH-3
AC CVCL_2856
DR BioSample; SAMN03470933
DR Cosmic; 2054110
DR Cosmic-CLP; 1290722
DR GDSC; 1290722
DR GEO; GSM827189
DR GEO; GSM1669602
DR JCRB; JCRB1073
DR JCRB; NIHS0269
RX PubMed=11686581;
RX PubMed=23833040;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; NIHS0269; true.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 12
ST D16S539: 9
ST D18S51: 13,17
ST D19S433: 13,15.2
ST D21S11: 28
ST D2S1338: 19,23
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 11
ST D8S1179: 16
ST FGA: 20,22
ST Penta D: 10,11
ST Penta E: 5
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ASHS2
AC CVCL_C549
DR CCRID; 3153C0001000000149
OX NCBI_TaxID=30527; ! Ovis ammon
SX Sex undetermined
CA Undefined cell line type
//
ID ASHS3
AC CVCL_C550
DR CCRID; 3153C0001000000150
OX NCBI_TaxID=30527; ! Ovis ammon
SX Sex undetermined
CA Undefined cell line type
//
ID ASimf20
AC CVCL_AZ82
SY Atlantic Salmon intestinal myofibroblast 20
RX CelloPub=CLPUB00326;
CC Group: Fish cell line.
OX NCBI_TaxID=8030; ! Salmo salar
SX Female
CA Spontaneously immortalized cell line
//
ID ASK
AC CVCL_4108
SY Atlantic Salmon Kidney
DR CLO; CLO_0001755
DR ATCC; CRL-2747
DR CCLV; CCLV-RIE 0926
DR GEO; GSM281567
DR GEO; GSM281568
DR GEO; GSM281569
DR GEO; GSM281570
DR GEO; GSM281571
DR GEO; GSM281572
RX PubMed=10785858;
RX PubMed=15825496;
RX PubMed=18534703;
RX PubMed=19941903;
CC Group: Fish cell line.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=8030; ! Salmo salar
SX Female
CA Spontaneously immortalized cell line
//
ID Aska-SS
AC CVCL_6C43
DR RCB; RCB3576
RX PubMed=20518020;
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ASO
AC CVCL_R967
SY Atlantic Salmon Ovary
RX PubMed=6767657;
CC Group: Fish cell line.
CC From: Gillespie J.H.; Cornell University College of Veterinary Medicine; Ithaca; USA.
OX NCBI_TaxID=8030; ! Salmo salar
SX Female
CA Spontaneously immortalized cell line
//
ID ASP309
AC CVCL_AZ83
SY Atlantic Salmon Pituitary 309
RX CelloPub=CLPUB00327;
CC Group: Fish cell line.
OX NCBI_TaxID=8030; ! Salmo salar
SX Female
CA Spontaneously immortalized cell line
//
ID ASP409
AC CVCL_AZ84
SY Atlantic Salmon Pituitary 409
RX CelloPub=CLPUB00327;
CC Group: Fish cell line.
OX NCBI_TaxID=8030; ! Salmo salar
SX Female
CA Spontaneously immortalized cell line
//
ID AsPC-1
AC CVCL_0152
SY AsPc-1; Aspc-1; ASPC-1; As-PC1; ASPC1; AsPC1; Aspc1; AsPc1
DR BTO; BTO:0001864
DR CLO; CLO_0001756
DR EFO; EFO_0002112
DR MCCL; MCC:0000044
DR CLDB; cl289
DR ATCC; CRL-1682
DR BCRC; 60494
DR BioSample; SAMN03471961
DR CCLE; ASPC1_PANCREAS
DR CCRID; 3111C0001CCC000214
DR CCRID; 3131C0001000700008
DR CGH-DB; 160-1
DR CGH-DB; 9271-4
DR ChEMBL-Cells; CHEMBL3307994
DR ChEMBL-Targets; CHEMBL612588
DR CLS; 300158/p611_AsPC-1
DR Cosmic; 707247
DR Cosmic; 710851
DR Cosmic; 724645
DR Cosmic; 808166
DR Cosmic; 868239
DR Cosmic; 872994
DR Cosmic; 910702
DR Cosmic; 913308
DR Cosmic; 918050
DR Cosmic; 922255
DR Cosmic; 923164
DR Cosmic; 932514
DR Cosmic; 933515
DR Cosmic; 947398
DR Cosmic; 948371
DR Cosmic; 948740
DR Cosmic; 949230
DR Cosmic; 1006364
DR Cosmic; 1090374
DR Cosmic; 1108341
DR Cosmic; 1198210
DR Cosmic; 1320465
DR Cosmic; 1366285
DR Cosmic; 1477433
DR Cosmic; 1571783
DR Cosmic; 1644318
DR Cosmic; 1995341
DR Cosmic; 2434085
DR Cosmic-CLP; 910702
DR ECACC; 96020930
DR GDSC; 910702
DR GEO; GSM206446
DR GEO; GSM495808
DR GEO; GSM621911
DR GEO; GSM784702
DR GEO; GSM886870
DR GEO; GSM887935
DR GEO; GSM1024396
DR GEO; GSM1374394
DR GEO; GSM1374395
DR GEO; GSM1374396
DR GEO; GSM1588607
DR GEO; GSM1669603
DR IGRhCellID; AsPC1
DR IZSLER; BS TCL 171
DR KCLB; 21682
DR NCBI_Iran; C558
DR PRIDE; PXD003198
DR SKY/M-FISH/CGH; 1997
RX DOI=10.4172/jpb.1000057;
RX PubMed=4023565;
RX PubMed=6582512;
RX PubMed=9185703;
RX PubMed=9665481;
RX PubMed=10027410;
RX PubMed=11169959;
RX PubMed=11787853;
RX PubMed=12692724;
RX PubMed=14695172;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=18380791;
RX PubMed=20418756;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/AsPC1.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=AsPC-1
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=66
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 46 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,13 (ATCC; CLS; Cosmic-CLP; KCLB; PubMed=25877200)
ST CSF1PO: 11,13 (ECACC)
ST D13S317: 9,12 (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)
ST D13S317: 12 (CLS)
ST D16S539: 11
ST D18S51: 18
ST D21S11: 28,30
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 12,13
ST D8S1179: 13,15
ST FGA: 24
ST Penta D: 9,12
ST Penta E: 5,12
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AsPC-1/CMV-Luc
AC CVCL_J243
DR JCRB; JCRB1454
DR JCRB; NIHS0697
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0697; true.
CC Derived from metastatic site: Ascites.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 9,12
ST D16S539: 11
ST D5S818: 12
ST D7S820: 12,13
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0152 ! AsPC-1
SX Female
CA Cancer cell line
//
ID ASPS-1
AC CVCL_S738
DR GEO; GSM1676317
DR GEO; GSM1701624
RX PubMed=21552147;
RX PubMed=26351324;
DI NCIt; C3750; Alveolar soft part sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ASPS-KY
AC CVCL_S737
DR Cosmic; 1333043
RX CelloPub=CLPUB00020;
RX PubMed=19380023;
DI NCIt; C3750; Alveolar soft part sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Asra-EPS
AC CVCL_W949
RX PubMed=23915498;
CC Doubling time: 38 hours (PubMed=23915498).
DI NCIt; C3714; Epithelioid sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AST
AC CVCL_S100
RX PubMed=7073944;
CC Doubling time: 40.7 hours (PubMed=7073944).
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AST-1
AC CVCL_0G16
RX PubMed=1319986;
RX PubMed=9738977;
DI NCIt; C3466; T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Astro 1
AC CVCL_6A98
RX PubMed=8365576;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID Astro 2
AC CVCL_6A99
RX PubMed=8365576;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID Astro 3
AC CVCL_6B00
RX PubMed=8365576;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID Astro 4
AC CVCL_6B01
RX PubMed=8365576;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID Astro.4U
AC CVCL_AQ52
WW http://axiogenesis.com/products/neuronal-cells/astro-4u-hipsc-astrocytes.html
CC From: Axiogenesis AG; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID ASTC-a-1
AC CVCL_C867
SY ASTCa1
DR BTO; BTO:0005015
CC From: Department of Medicine; Jinan University; China.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ASZ001
AC CVCL_6251
DR Lonza; 778
RX PubMed=16881970;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID AT
AC CVCL_E462
DR dbMHC; 48480
DR ECACC; 94022523
DR IHW; IHW9221
DR IMGT/HLA; 10268
WW http://bioinformatics.hsanmartino.it/ecbr/cl221.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AT(L)5KY
AC CVCL_2857
DR JCRB; JCRB0331
DR JCRB; KURB1795
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1G64 ! AT5KY
SX Male
CA Transformed cell line
//
ID AT(L)6KY
AC CVCL_2858
DR BioSample; SAMN03471622
DR JCRB; JCRB0332
DR JCRB; KURB1800
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 9,11
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1G66 ! AT6KY
SX Male
CA Transformed cell line
//
ID AT(L)7KY
AC CVCL_2859
DR BioSample; SAMN03471624
DR JCRB; JCRB0333
DR JCRB; KURB1806
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 9,13
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 9,12
ST D7S820: 11,13
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1G68 ! AT7KY
SX Male
CA Transformed cell line
//
ID AT-1
AC CVCL_6271
DR Lonza; 739
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Undefined cell line type
//
ID AT-2
AC CVCL_DI26
RX PubMed=12127395;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A300 ! UoC-B12
SX Male
CA Cancer cell line
//
ID AT-MS-1
AC CVCL_W198
RX PubMed=3761063;
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AT-PDH1TKB
AC CVCL_L558
DR CLO; CLO_0050715
DR BioSample; SAMN03472287
DR RCB; RCB0546
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C103968; Pyruvate dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AT13ABR
AC CVCL_IW68
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT1ABR
AC CVCL_M911
RX PubMed=2836804;
RX PubMed=7792600;
RX PubMed=9150358;
RX PubMed=9168117;
RX PubMed=11080496;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT1BE
AC CVCL_X707
DR ATCC; CRL-1312
RX PubMed=865488;
CC Discontinued: ATCC; CRL-1312; probable.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID AT1OS
AC CVCL_2860
DR BioSample; SAMN03471616
DR JCRB; JCRB0308
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9
ST D16S539: 9,12
ST D5S818: 10
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 10,11
ST vWA: 17,18
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AT22IJE-T
AC CVCL_D566
RX PubMed=2539904;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AT24
AC CVCL_M974
SY A-T24
RX PubMed=12080467;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT27RMO
AC CVCL_IW73
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT2ABR
AC CVCL_IW69
RX PubMed=2825700;
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT2BE
AC CVCL_V560
SY Se Pan
DR ATCC; CRL-1343
RX PubMed=865488;
RX PubMed=2973075;
RX PubMed=6810166;
RX PubMed=7471105;
CC Discontinued: ATCC; CRL-1343; probable.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AT2KY
AC CVCL_2861
DR BioSample; SAMN03471619
DR JCRB; JCRB0316
DR JCRB; KURB1777
DR JCRB; KURB1778
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 9,10
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 9,12
ST vWA: 18
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AT2KY TERT
AC CVCL_L457
DR JCRB; KURB1779
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2861 ! AT2KY
SX Female
CA Telomerase immortalized cell line
//
ID AT2SF
AC CVCL_V575
RX PubMed=2903889;
RX PubMed=2987007;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AT3ABR
AC CVCL_M912
RX PubMed=2825700;
RX PubMed=2836804;
RX PubMed=9150358;
RX PubMed=9168117;
RX PubMed=11080496;
CC Characteristics: Heterozygous for the ATM p.Lys2756Ter mutation.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT3B-1
AC CVCL_3489
SY AT3B1
DR CLO; CLO_0001760
DR ATCC; CRL-2375
DR ChEMBL-Cells; CHEMBL3308085
DR ChEMBL-Targets; CHEMBL613873
RX PubMed=9494564;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Breed/subspecies: Copenhagen.
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0146 ! R-3327-AT-3
SX Male
CA Cancer cell line
//
ID AT3B-2
AC CVCL_Y657
RX PubMed=9494564;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Breed/subspecies: Copenhagen.
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0146 ! R-3327-AT-3
SX Male
CA Cancer cell line
//
ID AT3BE
AC CVCL_X705
SY NeNo
DR ATCC; CRL-1347
CC Discontinued: ATCC; CRL-1347; probable.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID AT3BI
AC CVCL_V545
DR JCRB; KURB1821
RX PubMed=2987007;
RX PubMed=7471105;
RX PubMed=7471106;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AT3KY
AC CVCL_1G69
DR JCRB; KURB1786
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AT4BI
AC CVCL_V546
DR JCRB; KURB1761
RX PubMed=865488;
RX PubMed=2973075;
RX PubMed=6810166;
RX PubMed=7471106;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AT4BI(SV)
AC CVCL_4Y28
DR JCRB; KURB1762
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V546 ! AT4BI
SX Male
CA Transformed cell line
//
ID AT45LA
AC CVCL_N319
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT4ABR
AC CVCL_N288
RX PubMed=2836804;
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT4JTO
AC CVCL_M812
DR JCRB; KURB1810
RX PubMed=7057793;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AT4KY
AC CVCL_1G70
DR JCRB; KURB1787
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AT4KY TERT
AC CVCL_1G71
DR JCRB; KURB1788
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1G70 ! AT4KY
SX Male
CA Telomerase immortalized cell line
//
ID AT59
AC CVCL_M972
SY AT-59; AT 59; A-T59
RX PubMed=12080467;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT5ABR
AC CVCL_M913
RX PubMed=9150358;
RX PubMed=9168117;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT5BI
AC CVCL_7441
SY AT 5BI; GM05823; GM05823C; GM5823; GM5823A
DR CLO; CLO_0024679
DR Coriell; GM05823
DR JCRB; KURB1822
RX PubMed=2903889;
RX PubMed=2973075;
RX PubMed=6600729;
RX PubMed=6810166;
RX PubMed=6843573;
RX PubMed=7471105;
RX PubMed=7471106;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AT5BIVA
AC CVCL_7442
SY AT5BiSv40; AT5BISV40; GM05849; GM5849; GM05849B
DR CLO; CLO_0024705
DR Coriell; GM05849
DR Lonza; 258
DR TOKU-E; 4105
RX PubMed=2821020;
RX PubMed=3023120;
RX PubMed=11172010;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7441 ! AT5BI
SX Male
CA Transformed cell line
//
ID AT5KY
AC CVCL_1G64
DR JCRB; KURB1791
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AT5KY TERT
AC CVCL_1G65
DR JCRB; KURB1793
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1G64 ! AT5KY
SX Male
CA Telomerase immortalized cell line
//
ID AT76LA
AC CVCL_N320
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT79LA
AC CVCL_IW74
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT6ABR
AC CVCL_IW70
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT6KY
AC CVCL_1G66
DR JCRB; KURB1796
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AT6KY TERT
AC CVCL_1G67
DR JCRB; KURB1797
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1G66 ! AT6KY
SX Male
CA Telomerase immortalized cell line
//
ID AT7BI
AC CVCL_1G63
RX PubMed=2903889;
RX PubMed=7471106;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID AT7KY
AC CVCL_1G68
DR JCRB; KURB1804
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AT805
AC CVCL_8068
DR CLO; CLO_0050533
DR RCB; RCB1788
CC Breed/subspecies: 129.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID AT8ABR
AC CVCL_IW71
RX PubMed=2825700;
RX PubMed=2836804;
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AT9ABR
AC CVCL_IW72
RX PubMed=9150358;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID ATC-10
AC CVCL_Z222
SY ATC 10; ATC10; Singh's Aedes aegyptic cell line; ATP-10
DR CLO; CLO_0001670
DR CLDB; cl248
DR ATCC; CCL-125
DR ECACC; 87091801
RX CelloPub=CLPUB00178;
RX DOI=10.2307/3576172;
RX PubMed=5142320;
RX PubMed=6137452;
RX PubMed=6468178;
RX PubMed=16037617;
RX PubMed=16593348;
WW http://garfield.library.upenn.edu/classics1984/A1984SB92200002.pdf
WW https://www.vectorbase.org/data/aedes-aegypti-ccl-125-cell-line-avcl
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7159; ! Aedes aegypti
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-121
AC CVCL_Z224
RX CelloPub=CLPUB00179;
RX PubMed=6468178;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=317808; ! Aedes vittatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-136
AC CVCL_Z225
RX PubMed=5544717;
RX PubMed=6468178;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=69821; ! Aedes w-albus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-137
AC CVCL_Z226
RX PubMed=5544717;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=69821; ! Aedes w-albus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-15
AC CVCL_Z223
SY ATC 15; ATC15; Singh's Aedes albopictus cell line; Aa
DR CLO; CLO_0001627
DR CLO; CLO_0001671
DR CLDB; cl226
DR CLDB; cl249
DR CLDB; cl250
DR ATCC; CCL-126
DR ECACC; 90100401
DR IZSLER; BS CL 1
RX CelloPub=CLPUB00178;
RX PubMed=5142320;
RX PubMed=8799737;
RX PubMed=6468178;
RX PubMed=16037617;
WW http://garfield.library.upenn.edu/classics1984/A1984SB92200002.pdf
WW http://www.rccc.cytspb.rssi.ru/ecellbank/spinless/saa.htm
CC Group: Insect cell line.
OX NCBI_TaxID=7160; ! Aedes albopictus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-173
AC CVCL_Z227
RX PubMed=4691922;
RX PubMed=6468178;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=1579489; ! Aedes novalbopictus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-176
AC CVCL_Z228
RX PubMed=4691922;
CC Group: Insect cell line.
OX NCBI_TaxID=1579489; ! Aedes novalbopictus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-281/282
AC CVCL_Z911
RX PubMed=608719;
RX PubMed=791861;
CC Group: Tick cell line.
CC Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).
OX NCBI_TaxID=1134476; ! Haemaphysalis spinigera
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-304
AC CVCL_Z912
RX PubMed=791861;
CC Group: Tick cell line.
CC Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).
OX NCBI_TaxID=1256039; ! Haemaphysalis obesa
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-307
AC CVCL_Z913
RX PubMed=791861;
CC Group: Tick cell line.
CC Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).
OX NCBI_TaxID=34632; ! Rhipicephalus sanguineus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-308
AC CVCL_Z914
RX PubMed=791861;
CC Group: Tick cell line.
CC Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).
OX NCBI_TaxID=34632; ! Rhipicephalus sanguineus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-309
AC CVCL_Z915
RX PubMed=608719;
RX PubMed=791861;
CC Group: Tick cell line.
CC Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).
OX NCBI_TaxID=1134476; ! Haemaphysalis spinigera
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-310
AC CVCL_1B74
RX PubMed=791861;
CC Group: Tick cell line.
CC Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).
OX NCBI_TaxID=1256039; ! Haemaphysalis obesa
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-311
AC CVCL_Z916
RX PubMed=791861;
CC Group: Tick cell line.
CC Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).
OX NCBI_TaxID=1256039; ! Haemaphysalis obesa
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC-415
AC CVCL_Z229
RX DOI=10.1007/BF01666018;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=69822; ! Culex bitaeniorhynchus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ATC1
AC CVCL_C755
RX PubMed=15666850;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID ATCC-BXS0114
AC CVCL_X497
DR ATCC; ACS-1028
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID ATCC-BXS0115
AC CVCL_0A06
DR ATCC; ACS-1029
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID ATCC-BXS0116
AC CVCL_0A07
DR ATCC; ACS-1030
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID ATCC-BXS0117
AC CVCL_0A08
DR ATCC; ACS-1031
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID ATCC-BYS0110
AC CVCL_X496
DR ATCC; ACS-1024
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-BYS0111
AC CVCL_0A04
DR ATCC; ACS-1025
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-BYS0112
AC CVCL_0A05
DR ATCC; ACS-1026
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-BYS0113
AC CVCL_0A03
DR ATCC; ACS-1027
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-CYS0105
AC CVCL_X498
DR ATCC; ACS-1021
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 10,12
ST D5S818: 9,13
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-DYP0250
AC CVCL_C250
DR ATCC; ACS-1004
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2381 ! CCD-186Sk
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-DYP0530
AC CVCL_C251
DR ATCC; ACS-1014
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C254 ! ATCC-DYR0530
OI CVCL_C255 ! ATCC-DYS0530
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-DYP0730
AC CVCL_C252
DR ATCC; ACS-1003
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2430 ! Detroit 532
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-DYR0100
AC CVCL_C253
DR ATCC; ACS-1011
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 7,11
ST D13S317: 11,13
ST D16S539: 12
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3285 ! HFF-1
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-DYR0530
AC CVCL_C254
DR ATCC; ACS-1012
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C251 ! ATCC-DYP0530
OI CVCL_C255 ! ATCC-DYS0530
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-DYS0100
AC CVCL_X499
DR ATCC; ACS-1019
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 7,11
ST D13S317: 11,13
ST D16S539: 12
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3285 ! HFF-1
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-DYS0530
AC CVCL_C255
DR ATCC; ACS-1013
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C251 ! ATCC-DYP0530
OI CVCL_C254 ! ATCC-DYR0530
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-HYR0103
AC CVCL_C256
DR ATCC; ACS-1007
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 7,10
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ATCC-HYS0103
AC CVCL_X500
DR ATCC; ACS-1020
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 7,10
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ATDC-5
AC CVCL_3894
SY ATDC5
DR BTO; BTO:0001929
DR CLO; CLO_0050536
DR ECACC; 99072806
DR Lonza; 227
DR RCB; RCB0565
RX PubMed=2201423;
RX PubMed=23192741;
CC Breed/subspecies: 129.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_8068 ! AT805
SX Male
CA Cancer cell line
//
ID Atg3^(+/+)MEF
AC CVCL_1T21
SY Atg3 +/+ MEFs
DR RCB; RCB3708
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Atg3^(-/-)MEF
AC CVCL_1T22
SY Atg3 -/- MEFs
DR RCB; RCB3709
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Atg5^(+/+)MEF
AC CVCL_0J74
DR RCB; RCB2710
RX PubMed=15525940;
CC Breed/subspecies: C57BL/6 x 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Atg5^(-/-)MEF
AC CVCL_0J75
DR RCB; RCB2711
RX PubMed=15525940;
CC Breed/subspecies: C57BL/6 x 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID ATH8
AC CVCL_5206
SY ATH-8
DR ChEMBL-Cells; CHEMBL3307903
DR ChEMBL-Targets; CHEMBL614273
RX PubMed=2884263;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=ATH8
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Athos
AC CVCL_2298
SY ATHOS
DR CLO; CLO_0001763
DR CLDB; cl294
DR ECACC; 93122325
RX PubMed=8514246;
RX PubMed=1726925;
CC Misspelling: 'ARTHOS' in PubMed=1726925.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_2695 ! Porthos
CA Finite cell line
//
ID ATiPS-024
AC CVCL_Y524
SY AT-iPS-024
DR SKIP; SKIP000392
RX PubMed=24970375;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2860 ! AT1OS
SX Male
CA Induced pluripotent stem cell
//
ID ATiPS-262
AC CVCL_Y525
SY AT-iPS-262
DR SKIP; SKIP000393
RX PubMed=24970375;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2860 ! AT1OS
SX Male
CA Induced pluripotent stem cell
//
ID ATiPS-263
AC CVCL_Y526
SY AT-iPS-263
DR SKIP; SKIP000394
RX PubMed=24970375;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2860 ! AT1OS
SX Male
CA Induced pluripotent stem cell
//
ID ATiPS-264
AC CVCL_Y527
SY AT-iPS-264
DR SKIP; SKIP000395
RX PubMed=24970375;
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2860 ! AT1OS
SX Male
CA Induced pluripotent stem cell
//
ID ATL-10Y
AC CVCL_A415
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATL-16T
AC CVCL_0147
SY ATL16T
DR MCCL; MCC:0000040
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ATL-17-2
AC CVCL_6D78
RX PubMed=2972890;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATL-1K
AC CVCL_A406
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATL-2
AC CVCL_8338
SY ATL2
RX PubMed=11021758;
RX PubMed=11737246;
RX PubMed=16314839;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ATL-2M
AC CVCL_A407
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATL-35T
AC CVCL_8339
SY ATL35T
RX PubMed=16314839;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ATL-3I
AC CVCL_A408
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATL-43T
AC CVCL_8340
SY ATL43T
RX PubMed=16314839;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ATL-4K
AC CVCL_A409
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATL-5S
AC CVCL_A410
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATL-5T
AC CVCL_X530
DR CGH-DB; 9029-4
RX PubMed=9738977;
RX PubMed=2890613;
RX PubMed=10570904;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATL-6A
AC CVCL_A411
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ATL-7S
AC CVCL_A412
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATL-8K
AC CVCL_A413
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ATL-9Y
AC CVCL_A414
RX PubMed=6193528;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATN-1
AC CVCL_1073
DR CLO; CLO_0050985
DR BioSample; SAMN03472143
DR ChEMBL-Cells; CHEMBL3308183
DR ChEMBL-Targets; CHEMBL2366277
DR Cosmic; 910687
DR Cosmic-CLP; 910687
DR GDSC; 910687
DR GEO; GSM1669604
DR RCB; RCB1440
RX PubMed=3260813;
RX PubMed=9738977;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 10,13
ST D7S820: 8
ST TH01: 9
ST TPOX: 9
ST vWA: 14,18
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ATRFLOX
AC CVCL_2299
SY ATRFLOX [Mutatect]; ATRflox/-
DR CLO; CLO_0001764
DR EFO; EFO_0006535
DR ATCC; CRL-2780
DR BioSample; SAMN03472971
RX PubMed=11721054;
RX PubMed=25485619;
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 882; ATR.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 7,9
ST D13S317: 10,12
ST D16S539: 11,13
ST D18S51: 16,17
ST D21S11: 29,30
ST D3S1358: 12,19
ST D5S818: 10,12
ST D7S820: 11,12
ST D8S1179: 12,14
ST FGA: 18,23
ST Penta D: 9,13
ST Penta E: 13,14
ST TH01: 8,9
ST TPOX: 8
ST vWA: 17,22
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID ATRkd
AC CVCL_7947
SY GM847/ATRkd; ATR kinase dead
DR BTO; BTO:0003696
RX PubMed=9427750;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7908 ! GM00847
SX Male
CA Transformed cell line
//
ID Atrt95
AC CVCL_M154
RX PubMed=9786246;
DI NCIt; C6906; Atypical teratoid/rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AtT-20
AC CVCL_2300
SY AtT20; AtT 20; ATT-20
DR BTO; BTO:0001077
DR CLO; CLO_0001765
DR CLO; CLO_0001766
DR CLDB; cl296
DR ATCC; CCL-89
DR BCRC; 60244
DR CCRID; 3111C0001CCC000061
DR CCRID; 3131C0001000800001
DR ChEMBL-Cells; CHEMBL3307387
DR ChEMBL-Targets; CHEMBL614523
DR ECACC; 87021902
DR IZSLER; BS TCL 149
DR JCRB; JCRB9098
DR KCB; KCB 93012YJ
DR Lonza; 228
DR TOKU-E; 566
DR TOKU-E; 4284
RX PubMed=13874682;
RX PubMed=15541569;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-156.html
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID AtT-20/D16-16
AC CVCL_GZ35
DR TOKU-E; 3994
RX PubMed=2575458;
RX PubMed=6250490;
RX PubMed=6300893;
CC Misspelling: 'AtT-20/D16-8' in TOKU-E 3994.
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4W08 ! AtT-20/D16v
CA Cancer cell line
//
ID AtT-20/D16v
AC CVCL_4W08
SY AtT-20/D-16v; AtT-20/D 16v; AtT20D16v
RX PubMed=4312019;
RX PubMed=6250490;
RX PubMed=11383478;
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2300 ! AtT-20
CA Cancer cell line
//
ID AtT-20/D16v-F2
AC CVCL_4109
SY AtT20D16v-F2
DR CLO; CLO_0001767
DR CLDB; cl295
DR ATCC; CRL-1795
DR ECACC; 94050406
DR IZSLER; BS TCL 144
DR TOKU-E; 567
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4W08 ! AtT-20/D16v
CA Cancer cell line
//
ID AtT-20ins
AC CVCL_1G40
SY AtT-20 ins
RX PubMed=1309953;
RX PubMed=8325893;
RX PubMed=8433987;
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2300 ! AtT-20
CA Cancer cell line
//
ID AtT-20ins4b/1
AC CVCL_1G39
RX PubMed=6317196;
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2300 ! AtT-20
CA Cancer cell line
//
ID AU-BEK
AC CVCL_6533
SY AUBEK; Aubek; Auburn University - Bovine Embryonic Kidney
DR CLO; CLO_0001770
DR CLDB; cl297
RX PubMed=4798380;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aaubek.htm
OX NCBI_TaxID=9913; ! Bos taurus
CA Spontaneously immortalized cell line
//
ID AU10000
AC CVCL_2N35
DR CLO; CLO_0011292
DR Coriell; AU10000
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10001
AC CVCL_2N36
DR CLO; CLO_0011293
DR Coriell; AU10001
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10002
AC CVCL_2N37
DR CLO; CLO_0011298
DR Coriell; AU10002
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10003
AC CVCL_2N38
DR CLO; CLO_0011299
DR Coriell; AU10003
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID AU10004
AC CVCL_2N39
DR CLO; CLO_0011296
DR Coriell; AU10004
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10005
AC CVCL_2N40
DR CLO; CLO_0011297
DR Coriell; AU10005
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10006
AC CVCL_2N41
DR CLO; CLO_0011300
DR Coriell; AU10006
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10007
AC CVCL_2N42
DR CLO; CLO_0011330
DR Coriell; AU10007
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10008
AC CVCL_2N43
DR CLO; CLO_0011329
DR Coriell; AU10008
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10009
AC CVCL_2N44
DR CLO; CLO_0011328
DR Coriell; AU10009
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10010
AC CVCL_2N45
DR CLO; CLO_0011327
DR Coriell; AU10010
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10011
AC CVCL_2N46
DR CLO; CLO_0011326
DR Coriell; AU10011
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10012
AC CVCL_2N47
DR CLO; CLO_0011325
DR Coriell; AU10012
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10013
AC CVCL_2N48
DR CLO; CLO_0011324
DR Coriell; AU10013
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10014
AC CVCL_2N49
DR CLO; CLO_0011323
DR Coriell; AU10014
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10015
AC CVCL_2N50
DR CLO; CLO_0011322
DR Coriell; AU10015
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10016
AC CVCL_2N51
DR CLO; CLO_0011321
DR Coriell; AU10016
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10017
AC CVCL_2N52
DR CLO; CLO_0011338
DR Coriell; AU10017
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10018
AC CVCL_2N53
DR CLO; CLO_0011340
DR Coriell; AU10018
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10019
AC CVCL_2N54
DR CLO; CLO_0011339
DR Coriell; AU10019
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10020
AC CVCL_2N55
DR CLO; CLO_0011335
DR Coriell; AU10020
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10021
AC CVCL_2N56
DR CLO; CLO_0011334
DR Coriell; AU10021
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10022
AC CVCL_2N57
DR CLO; CLO_0011337
DR Coriell; AU10022
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10023
AC CVCL_2N58
DR CLO; CLO_0011336
DR Coriell; AU10023
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10024
AC CVCL_2N59
DR CLO; CLO_0011332
DR Coriell; AU10024
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10025
AC CVCL_2N60
DR CLO; CLO_0011331
DR Coriell; AU10025
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10026
AC CVCL_2N61
DR CLO; CLO_0011333
DR Coriell; AU10026
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10027
AC CVCL_2N62
DR CLO; CLO_0011306
DR Coriell; AU10027
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10028
AC CVCL_2N63
DR CLO; CLO_0011305
DR Coriell; AU10028
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10029
AC CVCL_2N64
DR CLO; CLO_0011304
DR Coriell; AU10029
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10030
AC CVCL_2N65
DR CLO; CLO_0011303
DR Coriell; AU10030
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10031
AC CVCL_2N66
DR CLO; CLO_0011310
DR Coriell; AU10031
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10032
AC CVCL_2N67
DR CLO; CLO_0011309
DR Coriell; AU10032
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10033
AC CVCL_2N68
DR CLO; CLO_0011308
DR Coriell; AU10033
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10034
AC CVCL_2N69
DR CLO; CLO_0011307
DR Coriell; AU10034
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10035
AC CVCL_2N70
DR CLO; CLO_0011302
DR Coriell; AU10035
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10036
AC CVCL_2N71
DR CLO; CLO_0011301
DR Coriell; AU10036
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10037
AC CVCL_2N72
DR CLO; CLO_0011320
DR Coriell; AU10037
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10038
AC CVCL_2N73
DR CLO; CLO_0011313
DR Coriell; AU10038
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10039
AC CVCL_2N74
DR CLO; CLO_0011312
DR Coriell; AU10039
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10040
AC CVCL_2N75
DR CLO; CLO_0011315
DR Coriell; AU10040
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10041
AC CVCL_2N76
DR CLO; CLO_0011314
DR Coriell; AU10041
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10042
AC CVCL_2N77
DR CLO; CLO_0011317
DR Coriell; AU10042
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10043
AC CVCL_2N78
DR CLO; CLO_0011316
DR Coriell; AU10043
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10044
AC CVCL_2N79
DR CLO; CLO_0011319
DR Coriell; AU10044
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10045
AC CVCL_2N80
DR CLO; CLO_0011318
DR Coriell; AU10045
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10047
AC CVCL_2N81
DR CLO; CLO_0011311
DR Coriell; AU10047
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10048
AC CVCL_2N82
DR CLO; CLO_0011370
DR Coriell; AU10048
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10049
AC CVCL_2N83
DR CLO; CLO_0011369
DR Coriell; AU10049
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10050
AC CVCL_2N84
DR CLO; CLO_0011367
DR Coriell; AU10050
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10051
AC CVCL_2N85
DR CLO; CLO_0011368
DR Coriell; AU10051
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10052
AC CVCL_2N86
DR CLO; CLO_0011365
DR Coriell; AU10052
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10053
AC CVCL_2N87
DR CLO; CLO_0011366
DR Coriell; AU10053
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10054
AC CVCL_2N88
DR CLO; CLO_0011363
DR Coriell; AU10054
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10055
AC CVCL_2N89
DR CLO; CLO_0011364
DR Coriell; AU10055
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10056
AC CVCL_2N90
DR CLO; CLO_0011361
DR Coriell; AU10056
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10057
AC CVCL_2N91
DR CLO; CLO_0011362
DR Coriell; AU10057
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10058
AC CVCL_2N92
DR CLO; CLO_0011378
DR Coriell; AU10058
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10059
AC CVCL_2N93
DR CLO; CLO_0011380
DR Coriell; AU10059
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10060
AC CVCL_2N94
DR CLO; CLO_0011379
DR Coriell; AU10060
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10061
AC CVCL_2N95
DR CLO; CLO_0011374
DR Coriell; AU10061
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10062
AC CVCL_2N96
DR CLO; CLO_0011375
DR Coriell; AU10062
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10063
AC CVCL_2N97
DR CLO; CLO_0011376
DR Coriell; AU10063
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10064
AC CVCL_2N98
DR CLO; CLO_0011377
DR Coriell; AU10064
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10065
AC CVCL_2N99
DR CLO; CLO_0011371
DR Coriell; AU10065
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10066
AC CVCL_2P00
DR CLO; CLO_0011372
DR Coriell; AU10066
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10067
AC CVCL_2P01
DR CLO; CLO_0011373
DR Coriell; AU10067
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10068
AC CVCL_2P02
DR CLO; CLO_0011350
DR Coriell; AU10068
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10069
AC CVCL_2P03
DR CLO; CLO_0011349
DR Coriell; AU10069
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10070
AC CVCL_2P04
DR CLO; CLO_0011348
DR Coriell; AU10070
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10071
AC CVCL_2P05
DR CLO; CLO_0011347
DR Coriell; AU10071
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10072
AC CVCL_2P06
DR CLO; CLO_0011343
DR Coriell; AU10072
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10073
AC CVCL_2P07
DR CLO; CLO_0011344
DR Coriell; AU10073
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10074
AC CVCL_2P08
DR CLO; CLO_0011341
DR Coriell; AU10074
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10075
AC CVCL_2P09
DR CLO; CLO_0011342
DR Coriell; AU10075
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10076
AC CVCL_2P10
DR CLO; CLO_0011345
DR Coriell; AU10076
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10077
AC CVCL_2P11
DR CLO; CLO_0011346
DR Coriell; AU10077
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10078
AC CVCL_2P12
DR CLO; CLO_0011356
DR Coriell; AU10078
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10079
AC CVCL_2P13
DR CLO; CLO_0011358
DR Coriell; AU10079
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10080
AC CVCL_2P14
DR CLO; CLO_0011357
DR Coriell; AU10080
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10081
AC CVCL_2P15
DR CLO; CLO_0011360
DR Coriell; AU10081
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10082
AC CVCL_2P16
DR CLO; CLO_0011359
DR Coriell; AU10082
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10083
AC CVCL_2P17
DR CLO; CLO_0011351
DR Coriell; AU10083
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10084
AC CVCL_2P18
DR CLO; CLO_0011352
DR Coriell; AU10084
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10085
AC CVCL_2P19
DR CLO; CLO_0011353
DR Coriell; AU10085
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10086
AC CVCL_2P20
DR CLO; CLO_0011354
DR Coriell; AU10086
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10087
AC CVCL_2P21
DR CLO; CLO_0011355
DR Coriell; AU10087
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10088
AC CVCL_2P22
DR CLO; CLO_0010938
DR Coriell; AU10088
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10089
AC CVCL_2P23
DR CLO; CLO_0010939
DR Coriell; AU10089
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10090
AC CVCL_2P24
DR CLO; CLO_0010940
DR Coriell; AU10090
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10091
AC CVCL_2P25
DR CLO; CLO_0010934
DR Coriell; AU10091
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10092
AC CVCL_2P26
DR CLO; CLO_0010935
DR Coriell; AU10092
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10093
AC CVCL_2P27
DR CLO; CLO_0010936
DR Coriell; AU10093
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10094
AC CVCL_2P28
DR CLO; CLO_0010937
DR Coriell; AU10094
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10095
AC CVCL_2P29
DR CLO; CLO_0010926
DR Coriell; AU10095
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10096
AC CVCL_2P30
DR CLO; CLO_0010929
DR Coriell; AU10096
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10097
AC CVCL_2P31
DR CLO; CLO_0010931
DR Coriell; AU10097
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10098
AC CVCL_2P32
DR CLO; CLO_0010959
DR Coriell; AU10098
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10099
AC CVCL_2P33
DR CLO; CLO_0010960
DR Coriell; AU10099
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10100
AC CVCL_2P34
DR CLO; CLO_0010957
DR Coriell; AU10100
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10101
AC CVCL_2P35
DR CLO; CLO_0010958
DR Coriell; AU10101
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10102
AC CVCL_2P36
DR CLO; CLO_0010955
DR Coriell; AU10102
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10103
AC CVCL_2P37
DR CLO; CLO_0010956
DR Coriell; AU10103
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10104
AC CVCL_2P38
DR CLO; CLO_0010953
DR Coriell; AU10104
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10105
AC CVCL_2P39
DR CLO; CLO_0010954
DR Coriell; AU10105
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10106
AC CVCL_2P40
DR CLO; CLO_0010949
DR Coriell; AU10106
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10107
AC CVCL_2P41
DR CLO; CLO_0010951
DR Coriell; AU10107
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10108
AC CVCL_2P42
DR CLO; CLO_0010966
DR Coriell; AU10108
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10109
AC CVCL_2P43
DR CLO; CLO_0010967
DR Coriell; AU10109
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10110
AC CVCL_2P44
DR CLO; CLO_0010968
DR Coriell; AU10110
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10111
AC CVCL_2P45
DR CLO; CLO_0010969
DR Coriell; AU10111
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10112
AC CVCL_2P46
DR CLO; CLO_0010970
DR Coriell; AU10112
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10113
AC CVCL_2P47
DR CLO; CLO_0010961
DR Coriell; AU10113
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10114
AC CVCL_2P48
DR CLO; CLO_0010962
DR Coriell; AU10114
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10115
AC CVCL_2P49
DR CLO; CLO_0010963
DR Coriell; AU10115
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10116
AC CVCL_2P50
DR CLO; CLO_0010964
DR Coriell; AU10116
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10117
AC CVCL_2P51
DR CLO; CLO_0010965
DR Coriell; AU10117
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10118
AC CVCL_2P52
DR CLO; CLO_0010975
DR Coriell; AU10118
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10119
AC CVCL_2P53
DR CLO; CLO_0010976
DR Coriell; AU10119
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10120
AC CVCL_2P54
DR CLO; CLO_0010979
DR Coriell; AU10120
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10121
AC CVCL_2P55
DR CLO; CLO_0010980
DR Coriell; AU10121
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10124
AC CVCL_2P56
DR CLO; CLO_0010977
DR Coriell; AU10124
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10125
AC CVCL_2P57
DR CLO; CLO_0010978
DR Coriell; AU10125
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10126
AC CVCL_2P58
DR CLO; CLO_0010973
DR Coriell; AU10126
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10128
AC CVCL_2P59
DR CLO; CLO_0010974
DR Coriell; AU10128
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10129
AC CVCL_2P60
DR CLO; CLO_0010971
DR Coriell; AU10129
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10130
AC CVCL_2P61
DR CLO; CLO_0010972
DR Coriell; AU10130
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10131
AC CVCL_2P62
DR CLO; CLO_0010987
DR Coriell; AU10131
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10132
AC CVCL_2P63
DR CLO; CLO_0010986
DR Coriell; AU10132
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10133
AC CVCL_2P64
DR CLO; CLO_0010985
DR Coriell; AU10133
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10134
AC CVCL_2P65
DR CLO; CLO_0010984
DR Coriell; AU10134
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10135
AC CVCL_2P66
DR CLO; CLO_0010983
DR Coriell; AU10135
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10136
AC CVCL_2P67
DR CLO; CLO_0010982
DR Coriell; AU10136
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10137
AC CVCL_2P68
DR CLO; CLO_0010981
DR Coriell; AU10137
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10138
AC CVCL_2P69
DR CLO; CLO_0010990
DR Coriell; AU10138
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10139
AC CVCL_2P70
DR CLO; CLO_0010989
DR Coriell; AU10139
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10140
AC CVCL_2P71
DR CLO; CLO_0010988
DR Coriell; AU10140
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10141
AC CVCL_2P72
DR CLO; CLO_0010996
DR Coriell; AU10141
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10142
AC CVCL_2P73
DR CLO; CLO_0010995
DR Coriell; AU10142
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10143
AC CVCL_2P74
DR CLO; CLO_0010998
DR Coriell; AU10143
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10144
AC CVCL_2P75
DR CLO; CLO_0010997
DR Coriell; AU10144
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10145
AC CVCL_2P76
DR CLO; CLO_0010992
DR Coriell; AU10145
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10146
AC CVCL_2P77
DR CLO; CLO_0010991
DR Coriell; AU10146
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10147
AC CVCL_2P78
DR CLO; CLO_0010994
DR Coriell; AU10147
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10148
AC CVCL_2P79
DR CLO; CLO_0010993
DR Coriell; AU10148
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10149
AC CVCL_2P80
DR CLO; CLO_0011000
DR Coriell; AU10149
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10150
AC CVCL_2P81
DR CLO; CLO_0010999
DR Coriell; AU10150
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10151
AC CVCL_2P82
DR CLO; CLO_0011010
DR Coriell; AU10151
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10152
AC CVCL_2P83
DR CLO; CLO_0011004
DR Coriell; AU10152
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10153
AC CVCL_2P84
DR CLO; CLO_0011003
DR Coriell; AU10153
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10154
AC CVCL_2P85
DR CLO; CLO_0011002
DR Coriell; AU10154
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10155
AC CVCL_2P86
DR CLO; CLO_0011001
DR Coriell; AU10155
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10156
AC CVCL_2P87
DR CLO; CLO_0011008
DR Coriell; AU10156
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10157
AC CVCL_2P88
DR CLO; CLO_0011007
DR Coriell; AU10157
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10158
AC CVCL_2P89
DR CLO; CLO_0011006
DR Coriell; AU10158
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10159
AC CVCL_2P90
DR CLO; CLO_0011005
DR Coriell; AU10159
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10160
AC CVCL_2P91
DR CLO; CLO_0011009
DR Coriell; AU10160
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10161
AC CVCL_2P92
DR CLO; CLO_0011019
DR Coriell; AU10161
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10162
AC CVCL_2P93
DR CLO; CLO_0011020
DR Coriell; AU10162
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10163
AC CVCL_2P94
DR CLO; CLO_0011012
DR Coriell; AU10163
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10164
AC CVCL_2P95
DR CLO; CLO_0011011
DR Coriell; AU10164
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10165
AC CVCL_2P96
DR CLO; CLO_0011014
DR Coriell; AU10165
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10166
AC CVCL_2P97
DR CLO; CLO_0011013
DR Coriell; AU10166
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10167
AC CVCL_2P98
DR CLO; CLO_0011016
DR Coriell; AU10167
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10168
AC CVCL_2P99
DR CLO; CLO_0011015
DR Coriell; AU10168
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10169
AC CVCL_2Q00
DR CLO; CLO_0011018
DR Coriell; AU10169
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10170
AC CVCL_2Q01
DR CLO; CLO_0011017
DR Coriell; AU10170
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10171
AC CVCL_2Q02
DR CLO; CLO_0011030
DR Coriell; AU10171
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10172
AC CVCL_2Q03
DR CLO; CLO_0011029
DR Coriell; AU10172
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10173
AC CVCL_2Q04
DR CLO; CLO_0011028
DR Coriell; AU10173
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10174
AC CVCL_2Q05
DR CLO; CLO_0011026
DR Coriell; AU10174
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10175
AC CVCL_2Q06
DR CLO; CLO_0011027
DR Coriell; AU10175
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10176
AC CVCL_2Q07
DR CLO; CLO_0011024
DR Coriell; AU10176
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10177
AC CVCL_2Q08
DR CLO; CLO_0011025
DR Coriell; AU10177
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10178
AC CVCL_2Q09
DR CLO; CLO_0011022
DR Coriell; AU10178
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10179
AC CVCL_2Q10
DR CLO; CLO_0011023
DR Coriell; AU10179
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10180
AC CVCL_2Q11
DR CLO; CLO_0011021
DR Coriell; AU10180
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10181
AC CVCL_2Q12
DR CLO; CLO_0011038
DR Coriell; AU10181
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10182
AC CVCL_2Q13
DR CLO; CLO_0011037
DR Coriell; AU10182
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10183
AC CVCL_2Q14
DR CLO; CLO_0011040
DR Coriell; AU10183
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AU10184
AC CVCL_2Q15
DR CLO; CLO_0011039
DR Coriell; AU10184
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU10185
AC CVCL_2Q16
DR CLO; CLO_0011033
DR Coriell; AU10185
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C88412; Autism spectrum disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AU565
AC CVCL_1074
SY AU-565; AU 565
DR BTO; BTO:0004737
DR CLO; CLO_0001769
DR EFO; EFO_0001087
DR ATCC; CRL-2351
DR BioSample; SAMN03470878
DR BioSample; SAMN03471449
DR CCLE; AU565_BREAST
DR ChEMBL-Cells; CHEMBL3308095
DR ChEMBL-Targets; CHEMBL1075393
DR Cosmic; 687462
DR Cosmic; 910704
DR Cosmic; 1136358
DR Cosmic; 1176652
DR Cosmic; 1309002
DR Cosmic; 1995342
DR Cosmic; 2165002
DR Cosmic-CLP; 910704
DR GDSC; 910704
DR GEO; GSM344340
DR GEO; GSM344390
DR GEO; GSM847196
DR GEO; GSM847451
DR GEO; GSM843441
DR GEO; GSM843442
DR GEO; GSM886871
DR GEO; GSM887936
DR GEO; GSM1421428
DR GEO; GSM1669605
DR LINCS; 50091
RX PubMed=17157791;
RX PubMed=20070913;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: MET genetic alteration cell panel (ATCC TCP-1036).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 10,13
ST D21S11: 30,30.2
ST D3S1358: 17
ST D5S818: 9,12
ST D7S820: 9,12
ST D8S1179: 11,12
ST FGA: 20
ST Penta D: 9,12
ST Penta E: 10,11
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0033 ! SK-BR-3
SX Female
CA Cancer cell line
//
ID AUC
AC CVCL_AV82
SY GM00328; GM0328; GM328
DR CLO; CLO_0025538
DR Coriell; GM00328
RX PubMed=2475503;
RX PubMed=2837086;
RX PubMed=5231733;
DI NCIt; C98944; Hereditary orotic aciduria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID AV3
AC CVCL_1904
SY AV 3; AV-3
DR CLO; CLO_0001771
DR CLO; CLO_0001772
DR CLO; CLO_0001773
DR CLDB; cl298
DR CLDB; cl299
DR ATCC; CCL-21
DR BioSample; SAMN03151665
DR BioSample; SAMN03471470
DR ECACC; 88102402
DR IZSLER; BS CL 3
DR KCLB; 10021
RX PubMed=1246601;
RX PubMed=20143388;
RX PubMed=23925245;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Genome sequenced (low read coverage).
CC Discontinued: KCLB; 10021; probable.
ST Source(s): ATCC; ECACC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3 (ATCC)
ST D13S317: 14 (ECACC)
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID Ava-BL
AC CVCL_7174
RX PubMed=12219084;
RX PubMed=16051863;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID AVC1
AC CVCL_W927
DR Cosmic; 966783
DR PRIDE; PXD002657
RX PubMed=14677066;
RX PubMed=26951071;
CC Doubling time: 24 +- 1 hours (PubMed=14677066).
CC Omics: Deep proteome analysis.
DI NCIt; C6650; Ampulla of Vater adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AVE-115
AC CVCL_4631
DR CLO; CLO_0001774
DR ATCC; CRL-6507
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6507; true.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID AVE,G
AC CVCL_E463
SY AVE, G
DR dbMHC; 48481
DR IHW; IHW9120
DR IMGT/HLA; 10274
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl120.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID AVG-16
AC CVCL_4110
DR ECACC; 06062701
RX PubMed=16848633;
RX PubMed=26667575;
CC Characteristics: Requires a media supplement called Ovagrow-S2A for continuous growth, but the company (Aivogen AG) producing this media does not exist anymore (personal communication from Horisberger M.A.).
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Conditionally immortalized cell line
//
ID AVL
AC CVCL_E464
SY GM06823
DR CLO; CLO_0036529
DR Coriell; GM06823
DR IHW; IHW0301
DR IMGT/HLA; 10275
RX PubMed=6417008;
WW http://bioinformatics.hsanmartino.it/ecbr/cl368.html
CC Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AVL/CTVM13
AC CVCL_Z140
DR TCB; 2961
RX PubMed=15053931;
RX PubMed=17662657;
RX PubMed=21955214;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=34610; ! Amblyomma variegatum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AVL/CTVM17
AC CVCL_Z141
SY AVL/CTVM 17
DR ECACC; 94022811
DR TCB; 2966
RX PubMed=15053931;
RX PubMed=17662657;
RX PubMed=22743047;
CC Group: Tick cell line.
CC Discontinued: ECACC; 94022811; probable.
OX NCBI_TaxID=34610; ! Amblyomma variegatum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID AVO
AC CVCL_EI30
DR Cosmic; 1071907
DR Cosmic; 1176607
DI NCIt; C9039; Cervical carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AVS
AC CVCL_HC48
RX PubMed=15220421;
CC Transformant: NCBI_TaxID; 10623; Cottontail rabbit papillomavirus (Kappapapillomavirus 2).
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Transformed cell line
//
ID AW 10498
AC CVCL_D651
RX PubMed=1691185;
CC Doubling time: 52.2 hours (PubMed=1691185).
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AW 13516
AC CVCL_D652
SY AW13516
RX PubMed=1691185;
CC Doubling time: 35.5 hours (PubMed=1691185).
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AW 8507
AC CVCL_D653
SY AW8507
RX PubMed=1691185;
CC Doubling time: 31.9 hours (PubMed=1691185).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AW 9803
AC CVCL_D654
RX PubMed=1691185;
CC Doubling time: 66 hours (PubMed=1691185).
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID AW-EBV-LCL
AC CVCL_L559
DR CLO; CLO_0051003
DR BioSample; SAMN03472140
DR RCB; RCB1437
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 7,10
ST D7S820: 11,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Aw3.18.14
AC CVCL_J158
DR CLO; CLO_0001775
DR ATCC; CRL-2826
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID AWCA
AC CVCL_ER22
SY CC-1
RX PubMed=1691480;
RX PubMed=8764055;
CC Characteristics: Contains two copies of the HPV18 genome.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AWELLS
AC CVCL_E465
SY Awells; WEL,AK; WEL, AK
DR dbMHC; 48482
DR ECACC; 94082236
DR IHW; IHW9090
DR IMGT/HLA; 11615
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl90.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AX0049
AC CVCL_8B82
DR ECACC; 91041816
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C126327; Usher syndrome type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AX0050
AC CVCL_8B83
DR ECACC; 91041817
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID AX0051
AC CVCL_8B84
DR ECACC; 91041818
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AX0052
AC CVCL_8B85
DR ECACC; 91041819
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AY-11
AC CVCL_6G28
SY AY 11; AY11; T 11
RX PubMed=7298281;
CC Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID AY-27
AC CVCL_S825
SY AY 27; AY27
RX PubMed=2936252;
RX PubMed=2981157;
RX PubMed=7298281;
RX PubMed=10574249;
RX PubMed=20404568;
RX PubMed=21424013;
CC Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID AY0001
AC CVCL_8B86
DR ECACC; 90112812
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID AY31
AC CVCL_6G27
SY AY 31; AY-31
RX PubMed=7298281;
CC Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID AY32
AC CVCL_6F40
SY AY 32; AY-32
RX PubMed=2981157;
RX PubMed=7298281;
CC Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID AY33
AC CVCL_6F41
SY AY 33; AY-33
RX PubMed=2981157;
RX PubMed=7298281;
CC Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID AY34
AC CVCL_6F42
SY AY 34; AY-34
RX PubMed=2981157;
RX PubMed=7298281;
RX PubMed=7448785;
CC Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID AZ-521
AC CVCL_2862
SY AZ 521; AZ521
DR CLO; CLO_0050792
DR EFO; EFO_0002814
DR BioSample; SAMN03151798
DR CCLE; AZ521_STOMACH
DR CGH-DB; 136-1
DR ChEMBL-Cells; CHEMBL3307904
DR ChEMBL-Targets; CHEMBL614274
DR Cosmic; 877047
DR Cosmic; 889108
DR Cosmic; 918495
DR Cosmic; 1066228
DR Cosmic; 1077281
DR Cosmic; 1187267
DR Cosmic; 1482080
DR Cosmic; 1518246
DR Cosmic; 2484969
DR GEO; GSM562393
DR GEO; GSM827401
DR GEO; GSM843443
DR GEO; GSM886872
DR GEO; GSM887937
DR GEO; GSM1374397
DR JCRB; JCRB0061
DR RCB; RCB2087
DR TKG; TKG 0185
RX PubMed=15723654;
RX PubMed=15767549;
RX PubMed=22460905;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
WW http://cell.brc.riken.jp/en/announcement/az521
CC Problematic cell line: Contaminated. Shown to be a Hutu 80 derivative (see JCRB web site).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): JCRB; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,11
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 9,11
ST TH01: 7
ST TPOX: 9,11
ST vWA: 16,18
DI NCIt; C7889; Duodenal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1301 ! HuTu 80
SX Male
CA Cancer cell line
//
ID AZ-H3c
AC CVCL_9480
SY AZ-H3C
RX PubMed=8609064;
DI NCIt; C7889; Duodenal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2862 ! AZ-521
SX Male
CA Cancer cell line
//
ID AZ-H6c
AC CVCL_9479
SY AZ-H6C
DR Cosmic; 873709
DR Cosmic; 888822
DR Cosmic; 1122337
DR Cosmic; 1187268
DR Cosmic; 1518243
RX PubMed=8609064;
DI NCIt; C7889; Duodenal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2862 ! AZ-521
SX Male
CA Cancer cell line
//
ID AZ303
AC CVCL_D300
RX PubMed=1423308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D301 ! AZ382
OI CVCL_D303 ! AZ390
SX Female
CA Cancer cell line
//
ID AZ364
AC CVCL_D302
RX PubMed=1423308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AZ382
AC CVCL_D301
RX PubMed=1423308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D300 ! AZ303
OI CVCL_D303 ! AZ390
SX Female
CA Cancer cell line
//
ID AZ390
AC CVCL_D303
RX PubMed=1423308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D300 ! AZ303
OI CVCL_D301 ! AZ382
SX Female
CA Cancer cell line
//
ID AZ402
AC CVCL_D304
RX PubMed=1423308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AZ403
AC CVCL_D305
RX PubMed=1423308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID AZ418
AC CVCL_D306
RX PubMed=1423308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D307 ! AZ419
SX Female
CA Cancer cell line
//
ID AZ419
AC CVCL_D307
RX PubMed=1423308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D306 ! AZ418
SX Female
CA Cancer cell line
//
ID AZH
AC CVCL_E466
DR dbMHC; 48483
DR ECACC; 94071439
DR IHW; IHW9293
DR IMGT/HLA; 10278
WW http://bioinformatics.hsanmartino.it/ecbr/cl293.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Azr3
AC CVCL_5A63
RX PubMed=954094;
CC Selected for resistance to: ChEBI; CHEBI:6198; (S)-azetidine-2-carboxylic acid (AZCA).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_5A61 ! V79 A3
SX Male
CA Spontaneously immortalized cell line
//
ID Azr7
AC CVCL_5A64
RX PubMed=954094;
CC Selected for resistance to: ChEBI; CHEBI:6198; (S)-azetidine-2-carboxylic acid (AZCA).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_5A61 ! V79 A3
SX Male
CA Spontaneously immortalized cell line
//
ID B 5
AC CVCL_J748
SY B5; M-28
DR CLO; CLO_0001818
DR ATCC; HB-8453
RX Patent=US4806628;
RX Patent=US4808704;
CC Discontinued: ATCC; HB-8453; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B-1-A-2
AC CVCL_U224
SY B-1
DR JCRB; JCRB0243
RX PubMed=3643104;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID B-23
AC CVCL_L176
DR KCLB; 60049
CC Breed/subspecies: BDIX.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID B-29
AC CVCL_W182
DR ATCC; CRL-6325
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6325; true.
CC Breed/subspecies: C3H/Crgl.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5840 ! Mm5MT
SX Female
CA Cancer cell line
//
ID B-3
AC CVCL_6367
AS CVCL_8482
SY HLE-B3; HLE B-3; HLEB-3; HLEB3; HLEC-B3
DR BTO; BTO:0002221
DR CLO; CLO_0001812
DR ATCC; CRL-11421
DR BioSample; SAMN03471336
RX Patent=US5643782;
RX PubMed=8206728;
RX PubMed=14578405;
CC Transformant: Ad12-SV40.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 9,11
ST D7S820: 11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID B-4
AC CVCL_D851
RX PubMed=8206728;
CC Transformant: Ad12-SV40.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID B-63
AC CVCL_4502
DR CLO; CLO_0001824
DR CLDB; cl5136
DR ATCC; CRL-6326
DR IZSLER; BS TCL 137
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6326; true.
CC Breed/subspecies: C3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID B-CPAP
AC CVCL_0153
SY BCPAP
DR BTO; BTO:0004736
DR CLO; CLO_0001906
DR MCCL; MCC:0000045
DR BioSample; SAMN03471001
DR CCLE; BCPAP_THYROID
DR ChEMBL-Cells; CHEMBL3308356
DR ChEMBL-Targets; CHEMBL1075394
DR Cosmic; 755292
DR Cosmic; 849970
DR Cosmic; 924104
DR Cosmic; 928836
DR Cosmic; 931241
DR Cosmic; 1084279
DR Cosmic; 1162847
DR Cosmic; 1237447
DR Cosmic; 1239965
DR Cosmic; 1280047
DR Cosmic; 1507369
DR Cosmic; 1533552
DR Cosmic; 1536122
DR Cosmic; 1889007
DR Cosmic; 2036692
DR Cosmic; 2054086
DR Cosmic; 2319847
DR Cosmic-CLP; 924104
DR DSMZ; ACC-273
DR GDSC; 924104
DR GEO; GSM886875
DR GEO; GSM887940
DR GEO; GSM1669612
DR NCBI_Iran; C596
RX PubMed=15172756;
RX PubMed=17725429;
RX PubMed=17804723;
RX PubMed=18713817;
RX PubMed=19087340;
RX PubMed=21868764;
RX PubMed=22087789;
RX PubMed=22460905;
RX PubMed=23162534;
RX PubMed=23833040;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=18713817; PubMed=21868764; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 13,17
ST D19S433: 13.2,15
ST D21S11: 30,31.2
ST D2S1338: 18
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 10
ST D8S1179: 12,13
ST FGA: 20,23
ST Penta D: 10,11
ST Penta E: 5,12,17
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID B-HM8
AC CVCL_J313
RX PubMed=6819484;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID B-R18
AC CVCL_CW55
DR NCBI_Iran; H168
WW http://www.neobiotechnologies.com/product_details.php?cat_no=355-MSM1-P0
CC Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID B-THP-1
AC CVCL_0R19
DR NIH-ARP; 9940-7
RX PubMed=10721995;
RX PubMed=14972530;
CC Problematic cell line: Misidentified. Originally thought to be THP-1 (PubMed=10721995) but later shown to be a derivative of Raji (PubMed=14972530).
CC Doubling time: ~20 hours (NIH-ARP).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0511 ! Raji
SX Male
CA Cancer cell line
//
ID B-THP-1/DC-SIGN
AC CVCL_0R20
DR NIH-ARP; 9941-52
RX PubMed=14972530;
CC Transfected with: HGNC; 1641; CD209.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0R19 ! B-THP-1
SX Male
CA Cancer cell line
//
ID B-thy-ts.1
AC CVCL_4W00
SY Bthy.ts1
RX PubMed=1374682;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Conditionally immortalized cell line
//
ID B/C.Li
AC CVCL_6F06
SY B/CLi; B/CL1
DR ATCC; CRL-6328
DR ATCC; CRL-6330
RX PubMed=4366196;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6328; true.
CC Discontinued: ATCC; CRL-6330; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID B/C.Ov
AC CVCL_6F07
SY B/C OV
RX PubMed=4366196;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID B/C.Sk
AC CVCL_7244
SY B/C SK
DR CLO; CLO_0001779
DR CLDB; cl329
DR ATCC; CRL-6329
DR ECACC; 86111901
RX PubMed=4366196;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6329; true.
CC Discontinued: ECACC; 86111901; probable.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID B/C3T3.We
AC CVCL_5925
DR CLO; CLO_0001780
DR ATCC; CRL-6327
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID B/CMBA.Ov
AC CVCL_5926
DR CLO; CLO_0001781
DR ATCC; CRL-6331
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S247 ! B/CMBA.Sp
OI CVCL_S353 ! B/CMBA.Ut
SX Female
CA Finite cell line
//
ID B/CMBA.Sp
AC CVCL_S247
DR ATCC; CRL-6332
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6332; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5926 ! B/CMBA.Ov
OI CVCL_S353 ! B/CMBA.Ut
SX Female
CA Finite cell line
//
ID B/CMBA.Ut
AC CVCL_S353
DR ATCC; CRL-6333
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6333; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5926 ! B/CMBA.Ov
OI CVCL_S247 ! B/CMBA.Sp
SX Female
CA Finite cell line
//
ID B/CWE
AC CVCL_5927
DR CLO; CLO_0001782
DR ATCC; CRL-6334
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6334; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID B0001
AC CVCL_T365
DR RCB; GMC0038
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: RCB; GMC0038; probable.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T364 ! A0001
SX Female
CA Transformed cell line
//
ID B0006
AC CVCL_T336
DR CLO; CLO_0050480
DR RCB; GMC0003
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID B0010
AC CVCL_T353
DR CLO; CLO_0050487
DR RCB; GMC0025
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T352 ! A0010
SX Female
CA Transformed cell line
//
ID B0022
AC CVCL_T344
DR CLO; CLO_0050494
DR RCB; GMC0016
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T345 ! A0022
SX Male
CA Transformed cell line
//
ID B0026
AC CVCL_T363
DR CLO; CLO_0050491
DR RCB; GMC0035
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T362 ! A0026
SX Female
CA Transformed cell line
//
ID B0031
AC CVCL_T339
DR CLO; CLO_0050481
DR RCB; GMC0005
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T338 ! A0031
SX Male
CA Transformed cell line
//
ID B0036
AC CVCL_T349
DR CLO; CLO_0050486
DR RCB; GMC0023
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID B0042
AC CVCL_T342
DR CLO; CLO_0050482
DR RCB; GMC0015
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T343 ! A0042
SX Male
CA Transformed cell line
//
ID B0045
AC CVCL_T361
DR RCB; GMC0034
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID B0050
AC CVCL_T355
DR CLO; CLO_0050489
DR RCB; GMC0030
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T354 ! A0050
SX Female
CA Transformed cell line
//
ID B0055
AC CVCL_T347
DR CLO; CLO_0050483
DR RCB; GMC0017
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T346 ! A0055
SX Male
CA Transformed cell line
//
ID B0058
AC CVCL_T358
DR CLO; CLO_0050488
DR RCB; GMC0029
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T357 ! A0058
SX Male
CA Transformed cell line
//
ID B0072
AC CVCL_T351
DR CLO; CLO_0050485
DR RCB; GMC0020
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T350 ! A0072
SX Female
CA Transformed cell line
//
ID B0076
AC CVCL_T356
DR CLO; CLO_0050496
DR RCB; GMC0026
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID B0078
AC CVCL_T359
DR CLO; CLO_0050490
DR RCB; GMC0032
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID B0082
AC CVCL_T334
DR CLO; CLO_0050479
DR RCB; GMC0001
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T335 ! A0082
SX Male
CA Transformed cell line
//
ID B0086
AC CVCL_T360
DR RCB; GMC0033
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID B0090
AC CVCL_T348
DR CLO; CLO_0050484
DR RCB; GMC0019
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID B0096
AC CVCL_T340
DR CLO; CLO_0050495
DR RCB; GMC0013
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID B02/GFP.2
AC CVCL_5T77
RX PubMed=11697798;
CC Transfected with: UniProtKB; P42212; GFP.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5T76 ! MDA-MB-231/B02
SX Female
CA Cancer cell line
//
ID B0317047
AC CVCL_8B87
DR ECACC; 03091135
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID B0403741
AC CVCL_8B88
DR ECACC; 04022036
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID B1 [Mouse embryonal carcinoma]
AC CVCL_1N71
SY AG13176
DR CLO; CLO_0022089
DR Coriell; AG13176
RX PubMed=2791350;
CC Breed/subspecies: CBA.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1N70 ! H6
CA Cancer cell line
//
ID B1 [Pig]
AC CVCL_F749
RX PubMed=2394515;
RX PubMed=7951345;
CC Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC Breed/subspecies: Miniature boar (d/d haplotype).
OX NCBI_TaxID=9823; ! Sus scrofa
SX Male
CA Transformed cell line
//
ID B1 NIH
AC CVCL_J977
SY B1
DR ATCC; HB-10572
RX Patent=US5612032;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID B1(NG)C39D
AC CVCL_1N73
SY AG13177
DR CLO; CLO_0022090
DR Coriell; AG13177
RX PubMed=2321096;
RX PubMed=2791350;
CC Breed/subspecies: CBA.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1N71 ! B1 [Mouse embryonal carcinoma]
CA Cancer cell line
//
ID B103
AC CVCL_D538
SY B-103
DR BTO; BTO:0004397
DR ChEMBL-Cells; CHEMBL3307905
DR ChEMBL-Targets; CHEMBL614275
RX PubMed=4151463;
WW http://www.addexbio.com/productdetail?pid=25
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: BDIX.
DI NCIt; C121567; Rat neuroblastoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Cancer cell line
//
ID B104 [Human lymphoma]
AC CVCL_M498
DR JCRB; JCRB0117
DR JCRB; NIHS0144
RX PubMed=1988498;
CC Discontinued: JCRB; NIHS0144; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C27907; B-cell neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID B104 [Rat neuroblastoma]
AC CVCL_0154
SY B-104
DR CLO; CLO_0001783
DR MCCL; MCC:0000046
DR CLDB; cl4955
DR ChEMBL-Cells; CHEMBL3307277
DR ChEMBL-Targets; CHEMBL614025
DR ICLC; ATL99008
RX PubMed=284369;
RX PubMed=4151463;
WW http://www.protocol-online.org/biology-forums-2/posts/10837.html
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Misspelling: Occasionally '8104'.
CC Breed/subspecies: BDIX.
DI NCIt; C121567; Rat neuroblastoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Cancer cell line
//
ID B104-1-1
AC CVCL_0396
DR CLO; CLO_0001784
DR CLDB; cl4944
DR ATCC; CRL-1887
DR BCRJ; 0272
DR ICLC; ATL98015
RX PubMed=6095109;
CC Transfected with: RGD; 2561; Erbb2 (with E-661).
CC Transformant: Activated Erbb2/neu.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID B104-R3
AC CVCL_2863
DR JCRB; JCRB0117.1
CC Discontinued: JCRB; JCRB0117.1; true.
DI NCIt; C27907; B-cell neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M498 ! B104 [Human lymphoma]
SX Male
CA Cancer cell line
** -----------------------------------------------------------------------
** CALIPHO group at the SIB - Swiss Institute of Bioinformatics
** Geneva, Switzerland
** -----------------------------------------------------------------------
**
** Description: References file for the Cellosaurus
** Version: 24.0
** Last update: 15-November-2017
**
** -----------------------------------------------------------------------
您正在向 biovector.net 发送关于产品 细胞株7-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
